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Abstract 
 Despite considerable research devoted to identifying biomarkers for ovarian cancer, no 
screening method is currently available for routine early detection of the disease.  While highly treatable 
in its early stages, a lack of symptoms early in the disease progression often results in the cancer 
spreading to other tissues before being diagnosed, significantly reducing the survival rate.  CA-125 is 
currently the most common biomarker used for the detection of ovarian cancer; however its poor 
diagnostic reliability when measured alone necessitates the use of a multiplexed biomarker screen for 
accurate early-stage diagnosis.  Numerous protein biomarkers have been identified for this purpose as 
well as small, noncoding oligonucleotides referred to as microRNAs.  New assays for screening this 
combination of multiple analyte types require the capability of detecting any class of target, including 
proteins and nucleic acids. 
 This work describes progress in developing a label-free, multiplexed assay for the early 
detection of ovarian cancer.  The instrumental approach exploits tiny microresonators that take 
advantage of a phenomenon referred to as whispering gallery mode (WGM) resonances.  This method is 
based on the ability of circular dielectrics to store light through continuous total internal reflection, 
where the wavelengths stored are dependent upon the surrounding refractive index.  By attaching 
capture agents to the sensor surface, binding events change the local RI and shift the resonant 
wavelength which can be used to quantify analyte binding.  To combine the favorable attributes of two 
traditional WGM techniques, in Chapter 2 we introduce a new approach for biosensing which combines 
microsphere WGM resonators with fluorescence imaging to create a flexible platform for multiplexed 
biosensing.  It is shown that the multiplexing capability is vastly increased using this imaging technique 
as compared to other WGM methods, enabling the detection of multiple targets in a single assay.  The 
feasibility of using this method for biomarker measurement is demonstrated by detecting two 
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biomarkers linked to ovarian cancer pathogenesis, CA-125 and tumor necrosis factor-α.  To advance the 
WGM imaging technique toward clinical use, we show in Chapter 3 that non-specific binding is not 
limiting by detecting CA-125 doped into serum samples.  The eventual clinical utility of this approach is 
illustrated by measuring CA-125 levels in serum collected from a healthy donor and a patient diagnosed 
with ovarian cancer.   
 Although whispering gallery detection is effective in biomarker measurement, in practice the 
sensing region covers a very small area.  As in all label-free assays, non-specific binding can be an 
issue for WGM detection and it is desirable that all immobilized antibodies be active.  It is crucial, 
therefore, that all capture antibodies are immobilized in the appropriate orientation for efficient analyte 
binding.  To maximize sensor performance, therefore, new techniques capable of characterizing 
antibody orientation at the single molecule level are required.  A new approach for measuring single 
antibody orientations is therefore introduced and validated in well-characterized test systems using 
model lipid membranes.   
 It has been shown that polarized total internal reflection fluorescence microscopy (PTIRF-M) is 
capable of directly determining the three-dimensional orientation of single molecules.  Using Langmuir-
Blodgett monolayers of DPPC, we show in Chapter 5 that these orientations can be used to track 
membrane structure at the molecular level.  We utilize this to find the characteristic “equivalent surface 
pressure” between lipid monolayers formed by Langmuir-Blodgett deposition and supported lipid 
bilayers formed by vesicle fusion.  The single molecule approach is further explored by comparing the 
condensing effects of sterol additives in each system.  These measurements show that orientations 
respond to the addition of condensing sterols, further supporting the notion that this technique can 
track structural changes at the molecular level.  As future single-molecule work will be used to 
determine antibody orientations in a dynamic, fluid environment, it is important to explore the time-
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resolved capabilities of this approach.  In Chapter 6 we show that single molecule orientational changes 
can be captured with ~1s temporal resolution.  By increasing the hydration levels of model membrane 
systems through changes in relative humidity, we show that both structural and dynamic changes occur 
within the membrane at the molecular level.  In addition, it was observed that this technique is capable 
of measuring three-dimensional orientational changes in real time.  Future goals include employing this 
method to probe antibody orientations on substrates in situ, so these studies are an important step for 
understanding how the technique may be applied in fluidic systems.   
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Chapter 1:  Introduction and Overview 
1.1 Ovarian Cancer 
 Ovarian cancer is both the most prevalent and deadly gynecological malignancy.1, 2   While it 
accounts for only ~3% of cancer cases in women, it is the fifth-leading cause of cancer related death, 
carrying a 1-in-70 lifetime risk and exhibiting a 60% fatality rate.1, 2   This fatality rate is not solely related 
to the aggressiveness of the disease, however, as the cancer is entirely treatable if caught early in its 
progression.  Consider the following graph, which illustrates the 5-year survival rate of women versus 
their diagnosed stage of ovarian cancer: 
Clearly, the early stages of this cancer are highly treatable, with survival rates of over 90%.1, 3, 4  These 
rates steadily decline from ~75%-35% between stages 2-3, until the disease advances well beyond the 
ovaries and invades other tissues, reaching a 5-year survival rate below 20% in stage four.2, 4, 5 
 What makes this disease a major issue facing society is the lack of early screens that enable 
routine detection.  A number of factors combine to make this disease elusive to diagnose at a more 
treatable stage.  Ovarian cancer is asymptomatic in its early stages when the malignant tissue is largely 
confined to the ovaries. This complicates early detection since the lack of early symptoms provides no 
Figure 1.1:  Ovarian cancer 5-year survival rate versus stage of diagnosis.  
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warning to screen during routine examinations.  When symptoms finally do appear, cancer progression 
makes surgical interventions difficult and much less effective at eliminating the infected tissue.  Because 
of the largely asymptomatic nature of ovarian cancer in early stages, over 70% of cases are diagnosed in 
some advanced stage, contributing to the difficulty of treatment.6  Clearly, new approaches that enable 
routine screening for early stage ovarian cancer are needed. 
1.2 Detection Methods in Ovarian Cancer Screening 
 1.2.1 The Physical Approach for Ovarian Cancer Detection 
 While early detection of this disease is difficult, physical methods can be used to aid in finding 
infected tissue.7  The physical approach involves the use of a pelvic ultrasound to image the ovaries.  
Abnormal masses of ~1cm or greater can be detected using this approach which can lead to further 
exams such as serum sampling or a biopsy.  While this technique is simple to perform and can be done 
in a point-of-care setting, it faces a number of issues.  The method is inherently problematic in that it 
can only detect tumors after they reach ~1cm in size.8  While locating tumors of this size confined to the 
ovaries would place diagnosis at stage 1, our goals are to push the point of diagnosis to the earliest point 
possible.  More importantly, this method is highly invasive, so it is not performed routinely and is 
utilized only after symptoms appear.  This pushes the stage of diagnosis to a later point, where 
successful treatment is much more difficult to achieve.  Although easy to perform and helpful for tumor 
detection, the physical approach is ill suited for routine screening and, therefore, early diagnosis.  This 
has motivated the ongoing effort to identify protein and other biomarkers in serum that correlate with 
the onset of disease pathogenesis. 
 1.2.2 Biomarkers for Ovarian Cancer Detection 
 The most widely utilized biomarker for detection of ovarian cancer is cancer antigen 125, or CA-
125.5, 9-15  While this protein biomarker is present in all women, its serum concentration is elevated in 
60% of women with ovarian cancer and 80% of women with disseminated ovarian cancer.1, 4, 5, 12, 16-18  
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Detecting elevated concentrations may be indicative of disease progression, but CA-125 is also elevated 
in 1% of healthy women, 3% with nonlethal ovarian diseases, and 6% with benign conditions such as 
pregnancy or menstruation.16-19  If only CA-125 concentration is measured, therefore, the false positive 
rate would be above medically acceptable levels.  To develop an early screen for ovarian cancer, 
multiple biomarkers must be measured routinely for effective diagnostic capability. 
 Since it is generally agreed that CA-125 levels alone are insufficient for early diagnosis of ovarian 
cancer, new and reliable targets must be identified.  Research in this field has found numerous 
candidate biomarkers; however, no single target has been found that exhibits the requisite diagnostic 
relevance.  To illustrate this problem, let us consider Table 1.1, which lists some identified potential 
targets for diagnostic use. 
Table 1.1:  Candidate biomarkers for ovarian cancer and their diagnostic capabilities. 
Biomarker Sensitivity Specificity Notes 
Protein    
Cancer 
antigen-125 
61%  
(Stage 1-2) 
86% 
(Stage 1-2) 
The most commonly screened protein for ovarian cancer 
diagnosis.  Poor performance alone. 5, 9-15   
HE4 86% (Stage 1) 
60% 
(Stage 1) 
Recently FDA approved for post-surgical relapse 
monitoring.20 
Osteopontin 70% 90% Up-regulated in early stage cancer.  Also implicated in cardiovascular disease.21 
Cathepsin L 80% 85% Elevated in ~80% of patients with Stage 1 carcinoma.22 
OVX-1 40% 80% Elevated in Stage 1 carcinoma.  Also implicated in breast and prostate cancer.23 
CA-72-4 54% 91% Also elevated in numerous cancers, such as breast, colon, pancreatic, and gastric carcinoma.23 
Prolactin 42% (Stage 1+2) 
90% 
(Stage 1+2) 
Also correlates with seizures, and breast, prostate, and 
colon cancers.21  
micro RNA    
miR-342-3p 80% 90% Down-regulated in ovarian cancer.24 
miR-141 -- -- While the sensitivity & specificity were not reported, miR’s 
141, 200a, and 205 were shown to be differentially 
expressed between healthy and diseased patients to a 
significant degree starting at stage 1 of ovarian 
carcinoma.25 
miR-200a -- -- 
miR-205 -- -- 
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In Table 1.1, diagnostic sensitivity is the probability of a test producing a true positive (positive test on 
an ill patient), defined as:26 =	 #	 	 	#	 	 	 #	 	 	    Eq. 1.1 
The diagnostic specificity is the probability of a test producing a true negative (negative test on a healthy 
patient), given by:26 =	 #	 	 	#	 	 	 #	 	 	    Eq. 1.2 
Finally, the positive predictive value (PPV) of a test is the probability that a person is actually infected 
when a positive result is seen.27  This is represented by: =	 #	 	 	#	 	 	 #	 	 	    Eq. 1.3 
The PPV is a defining quantity in the search for a successful screening strategy.  The consensus of 
researchers in clinical diagnostics is that in order for an assay to be acceptable for use in the general 
population, it must exhibit a PPV of 10%, translating to no more than nine false positives for each true 
positive.28  To reach a 10% PPV in the population of postmenopausal women who exhibit an ovarian 
cancer incidence of 40/100,000 per year, an acceptable assay for the disease must achieve a minimum 
of 99.6% specificity.28, 29  Considering the specificities outlined in Table 1.1, this stringent requirement is 
challenging for any single biomarker identified thus far.  It is these statistics that has led the clinical 
diagnostics community to agree that an assay which combines the measurement of multiple biomarkers 
is necessary for reliable routine ovarian cancer screening. 
 1.2.3 The Enzyme-Linked Immunosorbent Assay (ELISA) 
 A common assay employed for biomarker detection is the enzyme-linked immunosorbent assay, 
or ELISA.30  The method is based on the capture and subsequent detection of target proteins in biofluids 
utilizing antibody-antigen interactions which is outlined schematically in Figure 1.2. 
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Figure 1.2:  Sandwich-based ELISA method. 
By incubating a sample solution with the immobilized antibody, antigen affinity to the bound 
immunogen will capture the target on the substrate surface.  After binding occurs, a secondary antibody 
bound to an enzyme, such as horseradish peroxidase (HRP), is incubated with the antibody-antigen 
complex.  Following incubation, the captured antigen is “sandwiched” between the two antibodies, 
leaving the enzyme exposed to the surrounding buffer.  By adding a reagent such as 3,3’,5,5’-
tetramethylbenzidine (TMB) in the presence of hydrogen peroxide, HRP catalyze oxidation leads to the 
formation of a diimine product with a λmax of 450nm.31  The reaction is halted after adding an acidic stop 
reagent.  The measured absorbance at 450nm is then compared to a calibration curve and used to 
determine the protein concentration. 
 1.2.4 ELISA Advantages 
 The ELISA approach is widely accepted as the “gold standard” in the diagnostics community and 
has been utilized for many years due to its sensitivity, specificity, and robust nature.  Through employing 
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enzyme-catalyzed detection, the signal from TMB oxidation is amplified relative to incubation time, 
resulting in low detection limits.  Furthermore, by utilizing a secondary antibody for detection reduces 
cross-reactivity issues with the capture antibody, which increases analyte specificity.  Finally, the entire 
procedure can be performed on multi-well plates, allowing for automated protein detection.  These 
attributes make the ELISA technique appealing for biomarker measurement; however, the approach 
exhibits some serious drawbacks which make it challenging to implement in point-of-care settings for 
routine screening of ovarian cancer biomarkers. 
 1.2.5 ELISA Disadvantages 
 The first disadvantage with ELISA-based sensing is that it is considered a “one-shot” detection 
method:  detection of each target analyte requires a separate assay.  This creates logistical issues if the 
method is to be applied in routine multiplexed biomarker detection, as it scales poorly for point-of-care 
screening.  Scalability is also affected by reagent requirements, as continuous monitoring would be 
costly if numerous assays are performed on a regular basis.  Additionally, the immunoreactivity of the 
secondary antibody can be adversely affected by enzyme labeling.  Taking these issues into account, the 
ELISA approach, while effective for single-target monitoring, is ill-suited to achieving the necessary 
performance requirements of a routine multiplexed assay in the point-of-care setting. 
 Clearly, new approaches are needed for routine screening which can monitor multiple 
biomarkers simultaneously.  As there are a number of requirements to be addressed for such a 
screening technique, let us consider the attributes that an effective assay should exhibit. 
 1.3 Desired Performance Metrics for an Effective Ovarian Cancer Screening Assay 
 1.3.1 Multiplexed Biomarker Detection 
 The medical consensus is that a multiplexed biomarker assay capable of routine monitoring is 
required to achieve early diagnosis of ovarian cancer.  As discussed in Section 1.2.2, a PPV of 10% or 
better must be achieved to have an assay reliable enough for screening of the general population.28, 29  
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This requires a biomarker diagnostic sensitivity of 99.6%, and as seen in Table 1.1, no single biomarker 
has yet been found which can satisfy this requirement.28, 29   The assay must therefore be capable of 
multiplexed biomarker detection to achieve acceptable reliability. 
 1.3.2 Label-Free Detection 
 Referring back to Table 1.1, in addition to protein biomarkers for disease detection, recent work 
has suggested that small, noncoding ribonucleotides, called micro RNAs, can also act as signatures for 
ovarian cancer.25, 32-34  Introducing non-protein targets presents an additional requirement for the assay 
in that it must be capable of detecting numerous classes of target materials.  To achieve this type of 
detection, the most straightforward manner of sensing involves a label-free detection scheme.  This 
approach avoids the additional chemistry required by introducing labels which can also lead to a loss of 
biomolecule function.  Label-free detection, therefore, simplifies the chemistry and reduces the cost as 
fewer reagents are required.  These approaches also provide more flexibility in analyte detection, 
increase the speed of the assay, and are amenable with the point-of-care environment. 
 1.3.3 Low Detection Limits 
 ELISA is considered the “gold standard” in clinical diagnostics, due in part to its low detection 
limits, generally in the pM range.35  Our assay goals are to push these detection limits beyond the 
current capabilities of ELISA for several reasons.  First, research has shown that not only the absolute 
level of CA-125 and other biomarker concentrations is important for diagnosing ovarian cancer, but very 
small changes over time are indicators of cancer progression or relapse.36, 37  Also, the serum 
concentration of some identified biomarkers is either below the limits of detection in ELISA or totally 
absent in healthy individuals, so in order to capture their upregulation at the earliest stage of 
pathogenesis, we must strive to achieve the lowest limits of detection possible.37 
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 1.3.4 Point-of-Care Amenability 
 In addition to multiplexed biomarker detection, routine screening is necessary for diagnosing 
ovarian cancer in its early stages since during this time it is largely asymptomatic.  Numerous studies 
suggest that while the absolute concentration of biomarkers is important, the change of these levels 
over time both exhibits diagnostic importance and is helpful for monitoring the effectiveness of cancer 
treatment.36, 37  The eventual technique must be easily carried out in point-of-care settings for 
incorporation into well-woman examinations.  Since the goals of this method are to ultimately screen 
the general population, this stipulation requires that the approach be cost-effective.   
1.4 A Comparison of Common Label-Free Approaches to Biomarker Detection 
 Considering the criteria outlined in Section 1.3, there are numerous label-free methods which 
could potentially satisfy our goals.  The required criteria, such as good throughput, low cost, 
multiplexing capability and point-of-care applicability must all be taken into account when developing a 
screen.  Listed in Table 1.2 are popular label-free methods which are commonly used in biomarker 
detection.  In the following sections, we will consider each technique individually for comparison. 
 
Table 1.2:  Label-free approaches for biomarker detection. 
Sensing Technique Point of Care Applicability 
Multiplexing 
Capability 
Detection 
Limits Throughput Cost 
SPR38* Moderate Good uM-pM Good High 
Ellipsometry39 Difficult Moderate nM-pM Poor Moderate 
Interferometric 
Techniques40 
Moderate Poor pM-fM Poor Moderate 
Microcantilever 
Resonance41 
Very Difficult Poor ng/mL Good High 
Mass Spectrometry42, 43 Very Difficult Good μM-pM Moderate Very High 
Optical Resonator 
Sensors44 
Mixed Mixed 
μM to Single 
Molecule 
Mixed Moderate 
*Surface Plasmon Resonance 
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 1.4.1 Surface Plasmon Resonance 
 Surface plasmon resonance uses a metal coated dielectric material excited with incident laser 
light.  The valence electrons in the metal layer will absorb the incident radiation if it matches their 
collective oscillations, termed plasmons.  These resonances can be measured by examining the reflected 
light intensity as a function of reflection angle or wavelength.45  The plasmons are sensitive to refractive 
index changes in the region directly surrounding the metal coating.  By immobilizing capture materials 
such as antibodies on the metal surface, binding events may be measured in real time using this 
approach.  This method has multiplexing capabilities and appreciable throughput if used in an 
automated serial analysis approach or imaging format.  However, the detection limits of affordable 
designs are poor, and the technique is not generally amenable to point-of-care settings. 
 1.4.1 Ellipsometry 
 Ellipsometry uses the changes in the polarization of light as it is reflected from a target surface 
to measure the substrate’s dielectric properties and thickness.  Polarized light is reflected off the 
substrate surface and the polarization shift can be correlated to changes in the refractive index of the 
substrate.  This method can achieve detection limits ranging from nM to pM in antigen binding assays, 
providing good sensor performance at relatively low cost.39  The drawback to this approach is that it 
suffers from poor multiplexing capability and is challenging to integrate into a point-of-care setting. 
 1.4.2 Interferometry 
 Interferometric biosensors rely on the change in optical phase velocity resulting from 
biomolecule accumulation on a sensing strip coated with a recognition moiety.  For an example, Schmitt 
et al utilized a singular beam that was split and coupled into waveguides representing a sensing path 
and reference path.46  These two paths were subsequently recombined, and the resulting interference 
was used to measure the degree of analyte binding in the sensing path.  Techniques based on 
interferometry are very sensitive and exhibit detection limits in the femtomolar range.40  In addition, the 
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method is relatively cheap and has the capability of being applied in a point of care setting.  
Unfortunately, though, it suffers from poor multiplexing capabilities and has low throughput, limiting its 
usefulness for potential ovarian cancer screens. 
 1.4.3 Microcantilever Resonance Methods 
 Some interesting methods involving microcantilevers as balances have been explored as label-
free biosensors.  A small cantilever functionalized with a biorecognition element is oscillated at its 
natural resonance frequency in a sample solution.  The attachment of its target antigen causes a shift in 
the cantilever resonance frequency, which can be correlated to analyte concentration.  This method 
offers detection limits in the ng/mL range and has relatively good throughput, however the method is 
not user friendly and would be difficult to implement in a clinical lab setting.41  In addition, the 
instrumentation is somewhat expensive, and the approach is prone to artifacts that limit its robustness 
as a potential screen. 
 1.4.4 Mass Spectrometry  
 Mass spectrometry is used to measure the mass-to-charge ratio of charged materials and has 
proven to be extremely important in the discovery of protein biomarkers in numerous diseases.43  While 
effective in biomarker identification, mass spectrometry is better suited for qualitative purposes and has 
some difficulty when attempting to quantify targets.  In addition, it is highly cost-prohibitive and is not 
suitable for the point-of-care environment. 
 1.4.5 Optical Resonator Sensors 
 One very promising approach for label-free sensing exploits tiny microstructures that take 
advantage of a phenomenon referred to as whispering gallery mode (WGM) resonances.  These 
methods are based on the ability of circular dielectrics to store light through continuous total internal 
reflection.44  The wavelength that is supported within each structure is dependent on the surrounding 
refractive index (RI) and changes in the RI shifts the resonant wavelength that is supported within the 
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cavity.47  This phenomenon can be exploited as a sensing mechanism by immobilizing capture materials 
on the sensor surface.  Binding events at the sensor surface will change the local RI and shift the 
resonant wavelength which can be used to quantify analyte binding.44, 48  These techniques 
demonstrated excellent detection limits and are becoming increasingly popular for biomarker detection.  
In addition, their small size and relatively low cost make them ideal for point-of-care settings.  The goals 
of the research discussed here, therefore, are to combine the favorable metrics from several resonator 
designs to create a multiplexed assay amenable for routine ovarian cancer screens.  Before discussing 
their use in further detail, it is informative to first discuss the concept of total internal reflection, or TIR. 
1.5 Total Internal Reflection and the Evanescent Wave 
 Consider an incident beam of light passing from a medium of high refractive index to a medium 
of lower refractive index.  Snell’s law for light incident on the interface states that: =      Eq. 1.4 
 Where  and  are the refractive indices of the first and second medium, respectively, and  
and  are the incident and refracted angles of the light beam measured from the interface normal.  As 
light passes from a high index to a low index material, Snell’s Law states that the refracted light waves 
will be bent at greater angles from the surface normal as the incident angle increases.  This is shown 
schematically in Figure 1.5.  The point at which θ2 = 90°, results in all the light being reflected back into 
medium n2 and is referred to as the critical angle, θc: =            Eq. 1.5 
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Reaching and surpassing this incident angle results in a situation where light is no longer refracted into 
the less optically dense medium but is completely reflected into the medium of incidence.  This special 
condition is referred to as total internal reflection (TIR) and is illustrated by Figure 1.3.  Even though all 
of the light is reflected at the interface under TIR, there exist a non-propagating, exponentially decaying 
evanescent wave which extends into the second medium.  This is illustrated in Fig. 1.4.  This non-
propagating field extending into the second medium can excite molecules located near the interface.  
This phenomenon has been exploited extensively in fluorescence microscopy for surface sensitive 
measurements. 
 
Figure 1.4:  Exponential intensity decay of an evanescent wave.49 
Figure 1.3:  Light refraction and total internal reflection at the critical angle. 
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The intensity of this field is described by:49 = ⁄         Eq. 1.6 
Where Iz is the intensity of the field at distance z (perpendicular to the interface), I0 is the intensity of the 
field at the interface, and d is the penetration depth of the field, given by:49 =              Eq. 1.7 
where  and  is the refractive index of medium 1 and medium 2 in Fig. 1.3, respectively.  The depth is 
dependent on the incident wavelength, the refractive indices of the two materials, and the incident 
angle of the wave.  Generally, the penetration depth ranges from approximately 50-500nm for visible 
light.49 
 These are both useful phenomena – TIR is commonly exploited in both scientific and commercial 
applications, and the evanescent wave has uses in research-based applications.  Total internal reflection 
is the underlying principle which allows light to be guided long distances through fiber optics in 
telecommunications, and the evanescent field has been extensively employed as a noise-reduction 
technique in microscopy.  The work in this dissertation will be centered on exploiting both TIR and the 
evanescent field for bioanalytical applications ranging from biosensing to fundamental molecular 
studies. 
1.6 The Whispering Gallery Mode 
 As mentioned in Section 1.4.5, WGM resonators take advantage of continuous total internal 
reflection to confine light within their structures.44, 50-53  The term whispering gallery was first used by 
Lord Rayleigh in 1878 to describe an acoustical phenomenon observed in St. Paul’s Cathedral in London.  
Sound waves from whispers directed at one side of the dome would carry to the opposite side of the 
gallery, leading Rayleigh to suggest they were confined to the boundary of the dome.  A similar 
phenomenon can be observed in the continuous confinement of light within circular dielectrics.  
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Although the existence of this phenomenon has been known for many years, only recently has their 
usefulness and applicability in sensing started to emerge.44, 50 
 Figure 1.5 schematically illustrates the optical whispering gallery mode.  Light incident upon an 
interface undergoes total internal reflection.  If a dielectric sphere is brought near this boundary, light is 
coupled into the structure through interaction with the evanescent wave at the substrate surface.  If the 
sphere has a refractive index greater than its surroundings, light coupled into the structure undergoes 
total internal reflection at each interaction with the sphere surface as illustrated in Fig. 1.5.  When the 
roundtrip distance of the light within the sphere is an integer multiple of the coupled wavelength, the 
light coherently drives itself by returning in phase which leads to constructive interference.44, 52, 54, 55  On 
resonance, this constructive interference results in a build-up of light intensity within the sphere.  
This resonant condition is termed an optical whispering gallery mode, in tribute to the phrase coined 
over a century ago.  This phenomenon is quite useful for sensors and other applications and is at the 
epicenter of a rapidly emerging field of study.44, 50, 52, 56 
 For each resonator, there are specific wavelengths which may be efficiently trapped within the 
cavity under certain conditions.  These resonant wavelengths lead to enhanced light storage within the 
resonator, and arise when the following equation is satisfied.44, 47, 57 
=      Eq. 1.8 
Figure 1.5:  Ray tracing schematic of a whispering gallery mode. 
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In Eq. 1.8, λr is the resonant wavelength, r is the radius of the cavity, neff is the effective refractive index 
surrounding the sphere, and m is an integer multiple of the wavelength.  For sensing applications, the 
important value to consider in this equation is neff, as it takes into account the refractive index of the 
optical resonator as well as its surroundings.  Any changes in this value due to an alteration of the 
cavity’s surrounding refractive index will result in an alteration of λr.  By measuring changes in the 
resonant wavelength, therefore, WGMs may be exploited for sensing methods which rely on refractive 
index changes.   
 For biosensing applications, recognition elements may be bound to the resonator surface, and 
subsequent analyte binding will change neff and shift the resonant wavelength.44, 48  The shift in WGM 
resonance, therefore, can be used to track and quantify analyte binding without the use of labels.  
Further, since light confined in the WGM at resonance undergoes multiple revolutions within the 
cavity, the effective light-sample interaction length is significant, leading to low limits of detection.57 
 There are a number of challenges associated with WGM sensor development, such as 
expanding their use to multiplexed analyte detection and making them amenable for point-of-care 
screening.  The common implementations of WGM techniques, their advantages and drawbacks, as 
well as our progress in developing and improving a new approach to WGM sensing for biomarker 
measurement will be discussed in the chapters to come. 
1.8 Motivation and Overview of Dissertation 
 While much research is devoted to the identification and detection of ovarian cancer 
biomarkers, no screening method is currently available for early detection of the disease.6  This is due to 
the asymptomatic nature of the disease in its early stages, necessitating an accurate assay that can be 
routinely performed on the female population.  The research performed in this dissertation is motivated 
with the goal of developing a flexible, sensitive platform that can be used for multiplexed biomarker 
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detection.  While our intent revolves around ovarian cancer screens, the techniques developed here are 
general and will be widely amenable to other sensing applications. 
 In Chapter 2, the fundamental properties of WGMs are discussed and how the resonant 
condition can be exploited for biosensing purposes.58  Common approaches used for WGM biosensing 
are introduced along with a discussion of their merits and disadvantages in biosensor applications.59-62  
In an attempt to combine the favorable attributes of these techniques, we introduce a new approach for 
biosensing which combines microsphere WGM resonators with fluorescence imaging.  We show that the 
multiplexing capability is vastly increased using this imaging approach, enabling the detection of 
multiple targets in a single assay.  The feasibility of using this method for biomarker measurement is 
demonstrated by detecting two biomarkers linked to ovarian cancer pathogenesis. 
Chapter 3 introduces a simplified method for launching WGMs into labeled microspheres by 
employing a Dove prism; this approach enables much larger fields of spheres to be excited and imaged.  
To advance the WGM imaging technique toward clinical use, we also show that non-specific binding is 
not limiting by detecting CA-125 doped into serum samples.  The eventual clinical utility of this approach 
is illustrated by measuring CA-125 levels in serum collected from a healthy donor and a patient 
diagnosed with ovarian cancer.  In addition, through changes to the instrumentation, the increase in 
signal to noise has revealed that the mode structure within each microsphere cavity can be imaged 
using this approach, providing exciting new opportunities for measuring analyte binding.  Finite element 
analysis is introduced to assist in exploring resonator geometries and conditions which lead to changes 
in the fundamental mode structure observed with analyte binding.63, 64 
 Although whispering gallery detection is effective in biomarker measurement, in practice the 
sensing region covers a very small area.  As in all label-free assays, non-specific binding can be an 
issue for WGM detection and it is highly desirable that all immobilized antibodies be active.  It is 
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crucial, therefore, that all capture antibodies are immobilized in the appropriate orientation for efficient 
binding of target analytes.65-67  Chapter 4 discusses current techniques employed for antibody 
immobilization, as well as common methods used for measuring the resulting antibody activity.65-73  
Since binding strongly depends on antibody orientations on the surface, we discuss the challenges 
associated with measuring these orientations.  Current techniques involve indirect measurements or are 
performed using ensemble averaged methods, which reduces site-specific information.  To maximize 
sensor performance, therefore, new techniques capable of characterizing antibody orientation at the 
single molecule level are required.  Chapter 4 discusses our work to employ an emerging fluorescence 
technique to characterize the three-dimensional orientation of single molecules.  To test and validate 
this method, we present studies on well-characterized test systems, using model lipid membranes.  This 
groundwork will allow for the eventual use of single-molecule orientation measurements to probe 
antibody orientation as a function of immobilization chemistry, thus maximizing the potential of 
antibody-based sensors. 
 Previous studies have shown that polarized total internal reflection fluorescence microscopy 
(PTIRF-M) is capable of directly determining the three-dimensional orientation of single molecules.74-78  
We exploit this approach in Chapter 5, and extract the orientation of single molecule reporter probes to 
examine the structural characteristics of DPPC model membrane films at the molecular level.79  We then 
utilize this technique to find the characteristic “equivalent surface pressure” between lipid monolayers 
formed by Langmuir-Blodgett deposition and supported lipid bilayers formed by vesicle fusion.  The 
single molecule approach is further explored by comparing the condensing effects of sterol additives in 
each system.  This method is therefore capable of measuring heterogeneous properties of supported 
films at the molecular level, and is an appealing compliment to bulk measurements of membrane 
properties. 
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 Our single-molecule studies to this point are employed on static systems in a dry atmosphere.  
As future single-molecule work will be used to determine antibody orientations in a dynamic, fluid 
environment, it is important to explore the time-resolved capabilities of this approach.   In Chapter 6 we 
explore the effects of hydration on model membrane structure using single-molecule orientations.80  We 
show that by increasing the hydration levels of model membrane systems, both structural and dynamic 
changes occur within the membrane at the molecular level.  We also observe that this technique is 
capable of measuring three-dimensional orientational changes in real time.  Future goals include 
employing this method to probe antibody orientations on substrates in situ, so these studies are an 
important step for understanding how the technique may be applied in fluidic systems.   
 Having tested and validated the single-molecule orientation approach, Chapter 7 introduces our 
initial research directed at examining antibody orientations.  The antibody 4-4-20 and its binding 
properties to the fluorescent probe Fluo-3 are discussed which will serve as the model system.81, 82  
Initial studies suggest that the Fluo-3 fluorophore is sufficiently fluorescent for single-molecule studies, 
making it feasible for measuring its orientation while present in its corresponding antibody complex.  In 
the context of WGM sensor development, additional studies towards improving sensor performance are 
presented, including the optimization of dye loading increase resonator Q-factor.  An approach to 
reduce the whispering gallery mode volume is also discussed as a potential improvement on WGM 
sensitivity to protein binding. 
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Chapter 2:  Employing a Fluorescence-Based Approach to Whispering Gallery Mode Imaging 
2.1 The Whispering Gallery Resonator 
 Whispering gallery mode resonances arise when light is efficiently coupled into and stored 
within circular dielectric cavities.  A number of different geometries are currently employed to achieve 
WGM excitation and detection, each possessing its own merits and disadvantages.  Before discussing 
these various techniques, let us first consider the uses of these structures as sensing platforms, and how 
their performance is measured.  
 2.1.1 Employing Whispering Gallery Resonators for Biomarker Detection 
 The resonant condition of a WGM structure can be expressed by:1-3 =      Equation 2.1 
where  is the resonant wavelength, r is the radius of the structure, m is an integer multiple of the 
wavelength, and  is the effective refractive index, which takes into account the refractive indices of 
both the resonator and its surroundings.  If a biological recognition element, such as an antibody, is 
bound to the resonator surface, binding of the target antigen changes  in Eq. 2.1 and results in a 
shift of the resonant condition,4, 5 as illustrated in Figure 2.1.  The magnitude of the shift is given by 
Figure 2.1:  Resonant wavelength changes due to antigen binding. 
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Equation 2.2:6, 7 
=     Equation 2.2 
where ns and nm are the refractive indices of the sphere and the surrounding medium, respectively.   
is the excess polarizability,  is the surface coverage of the target biomarker,  is the vacuum 
permittivity, and r is the radius of the sphere.  The dependence of the resonant wavelength on the 
surrounding refractive index is the central property that is exploited in WGM-based general sensing 
platforms.  An important attribute of the sensor performance is how efficiently they trap light within the 
resonator.  A number of independent factors affect this efficiency, and their collective contributions 
comprise a term referred to as the quality factor (Q-factor).  The magnitude of the Q-factor is related to 
the overall performance metrics of a WGM resonator. 
 2.1.2 Resonator Q-factors and Their Impact on Detection Capabilities 
 The quality of a resonator is qualified by the Q-factor and is related to the efficiency of the 
cavity to confine light through continuous total internal reflections.  It is empirically defined as: =      Equation 2.3 
where  is the resonant wavelength, and  is the full width at half maximum of the resonant 
wavelength intensity. 
 High Q resonators have very low light attenuation, and light trapped within these structures 
undergo multiple revolutions within the cavity. For sensing applications, high Q resonators result in 
increased light-sample interaction and improved sensor performance.  It is therefore advantageous to 
strive for the highest possible Q-factor when designing WGM resonators.  If we consider a sphere 
undergoing WGM excitation, the inherent Q factor of the structure has four independent 
contributions:1, 8 =	 + + . . +         Equation 2.4 
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where  characterizes the radiative losses associated with bending losses within the spherical 
cavity.1, 8  These losses increase exponentially as sphere size decreases.  For spheres with diameters ≥ 
15λ, these losses essentially vanish.   accounts for light attenuation due to material absorption of 
the circulating wave by the resonator structure.  The Q-factor limitation due to  can be 
approximated by:1, 8 =       Equation 2.5 
Where  is the refractive index,  is the material attenuation and λ is the wavelength.  As an example, 
using fused silica and a wavelength of 633 nm, the Q factor is limited by  to approximately 9	 	10 . 
 The major limiting factor for spheres ranging from ~40-80 μm in diameter is . ., which 
accounts for surface scattering losses on the sphere due to imperfections.1, 8  Using reasonable values 
for scratch-dig inhomogeneities in fused silica, the fundamental Q-factor limit due to . . ranges from ~3x109 to ~6x109 for 40-80μm sized spheres. 
  is based on contributions from surface contaminants present on the sphere surface during 
fabrication; previous work demonstrated that a time-dependent process involving the adsorption of 
oxygen followed by atmospheric water on silicon dioxide resonators was the inherent mechanism that 
limited the Q-factor of fused silica resonators formed via microtorch.1 
 All of the above mechanisms contribute to the intrinsic Q-factor of a WGM resonator.  Since the 
Q-factor characterizes the number of photon revolutions in a cavity, the effective path length, Leff, is 
given by:1, 3 =      Equation 2.6 
This refers to the effective light-sample interaction length, and sensitivity and detection limits in turn 
will improve as this quantity is increased.  As an example, using a Q-factor of ~4.5x109 at a wavelength 
of 633nm in fused silica, the effective light-sample interaction length is 352 meters!  This immense value 
illustrates the extraordinary capabilities afforded by using this technique for biomolecule detection. 
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 The Q factor of WGM resonators influences the minimum measurable shift in resonant 
wavelength due to changes in the surrounding refractive index, and is represented by:7  (Δ ) = ∗     Equation 2.7 
where  is the resonant wavelength and F is a “measurement acuity factor” which factors in 
experimental noise and the spectral bandwidth of the detection system.  Finally, the biomolecule 
surface density detection limit of a WGM resonator is given by:6, 7 
= ( / )     Equation 2.8 
where  is the radius of the resonator,  is the excess polarizability of the biomolecule,  is the 
vacuum permittivity, and  and  are the refractive indices of the resonator and surrounding 
medium, respectively.  Eq. 2.6 suggests that to achieve the best limits of detection, r/Q must be 
minimized.  This is difficult since Q is dependent on r, and reducing r will decrease the inherent Q factor 
due to contributions from .  Consequently, the size of spheres used in WGM sensing should be 
minimized, but not to diameters below ~10μm since radiative losses will degrade the inherent Q factor.  
Using a sphere with a diameter of 50μm and a Q-factor of 4.5x109, the  for detection of bovine 
serum albumin is ~1.7 fg/mm2, several orders of magnitude lower than the best detection limits 
reported for SPR sensing, at ~1 pg/mm2.9  This shows that WGM sensing compares favorably with other 
label-free techniques used in refractive index and biomolecule detection.10 
 2.1.3 Sensing Approaches Using WGM Resonators 
 Experimentally, coupling light into WGM resonators is challenging to do efficiently.  Exciting 
resonances in these structures requires using a phase-matched source optically coupled in the near 
field.11  Free-space coupling into a WGM structure is very inefficient since the refractive indices of the 
two mediums are mismatched.  Methods used to excite these resonances typically employ an index-
matched material undergoing total internal reflection.2, 7  Bringing a WGM resonator into the near-field 
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of the resulting evanescent wave causes light to couple into the resonator via frustrated total internal 
reflection.  Several approaches can be used for this excitation, such as prism couplers, waveguides, and 
tapered fiber optics.6-8  The similarity between these methods is that they are all based on light 
tunneling from a pump source into the dielectric resonator.  While coupling can be a logistical issue in 
WGM instrumentation, the technique must also be capable of both exciting these resonances and 
recording the resulting resonant wavelength as well.  Because the spectral linewidth of WGM 
resonances is exceedingly small (δλ = 0.14 fm at 633 nm with a Q-factor of 4.5x109), tunable lasers used 
for excitation must have very narrow spectral bandwidths.7  A variety of methods utilizing different 
geometries have been employed to meet these requirements.1, 3, 6-8 
 
Figure 2.2:  Microsphere-based WGM excitation and detection. 
 A common approach used for WGM detection with microsphere resonators involves a tunable 
laser launched into an optical fiber with an adiabatically tapered region.2, 5  Light is coupled into the 
microsphere resonator using the evanescent field generated from the exposed fiber core at the tapered 
region. As the laser wavelength is scanned, a dip is observed in the light intensity transmitted through 
the fiber as the microsphere experiences a WGM resonance, as seen in Fig. 2.2. The dip reflects 
increased coupling of light from the fiber into the microsphere at the WGM resonance, resulting in a 
decrease of light transmitted to the distal end of the fiber.  
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 Another commonly employed approach for WGM excitation utilizes high-index planar 
resonators coupled via on-chip waveguide structures.12, 13  These resonators are fabricated in clean-
room facilities by modern photolithographic techniques.  An example of such a resonator is illustrated in 
Figure 2.3.  In this experimental setup, a planar ring resonator and waveguide coupler comprised of 
fused silica are fabricated using photolithography.  In order to excite WGMs of the ring structure, light is 
free-space coupled into the waveguide either through a grating coupler or by focusing light into the 
proximal end of the high index structure.13  The gap between the linear waveguide and the resonator 
structure is designed to provide sufficient overlap of the evanescent field from light propagating through 
the waveguide with the ring resonator.  As the wavelength of the excitation beam is tuned, WGM 
resonances in the ring structure are read out as transmission dips at the distal end of the waveguide on 
the microchip, similar to the approach used in fiber taper coupling.13 
 Of these two approaches for WGM sensing, microspheres exhibit the highest experimental Q-
factors due to their fabrication by melting, causing them to surfaces to be extremely smooth and 
spherical.  The greatest Q-factor observed using microspheres thus far is 109, as reported by Gorodetsky 
et al.1  Microsphere-based methods are simple to employ and have been utilized for the detection of a 
wide array of materials due to their versatility.  Initial work using this approach was reported by Vollmer 
et al. and involved the detection of streptavidin by microsphere resonators coated with biotinylated 
Figure 2.3:  Microfabricated, waveguide-coupled planar ring WGM resonator. 
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BSA.5  Saturation of their sensor through streptavidin injections was achieved at concentrations at or 
below 20 nM.  The same group later reported multiplexing capability using this technique through the 
simultaneous detection of two ssDNA targets using two microspheres separately functionalized with 
complimentary sequences, showing limits of detection reaching 6 pg/mm2.14  Further work in this field 
by Hanumegowda et al. involved using protein coated microspheres to measure protease activity.15  The 
authors stated that by using BSA-coated microspheres, instead of the traditional red-shift associated 
with analyte binding,  blue-shifting of resonant frequencies after trypsin injections was attributed to 
protein digestion and removal.  The limit of detection for trypsin using this approach was projected to 
be ~0.43 pM.15  Using aptamer-based capture techniques, Fan’s group later demonstrated the detection 
of thrombin on microsphere resonators, with limits of detection reaching ~23 nM.16  Studies using this 
approach also include the measurement of additional oligonucleotides17, heavy metal ions18, and 
bacteria19.  The major drawbacks to this technique are the logistical issues associated with finding the 
optimal location along the tapered fiber for optimal sphere coupling, and the mechanical fragility of the 
fiber taper itself.  Moreover, scaling up this approach to detecting numerous targets is extremely 
difficult.  The most amount of multiplexing reported using this method was by measuring two DNA 
targets;14 further multiplexing using this technique has yet to be reported.  This limitation has garnered 
interest toward other avenues of WGM excitation and sensing, most notably those formed via 
microfabrication techniques. 
 In microfabrication-based WGM sensing, the planar ring structure is chemically modified to 
incorporate a capture material such as a monoclonal antibody.13, 20  This approach yields additional 
multiplexing capability since an array of ring resonators can be fabricated in parallel.  By creating optical 
resonator sensors on a rigid substrate through scalable processes such as photolithography, possibilities 
are opened up that allow for both automated and multiplexed target detection.  Using this approach, 
Bailey’s group has recently reported the multiplexed detection of five cancer biomarkers in complex 
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media, displaying the efficacy of planar optical resonators for biomarker detection.20  This method takes 
an additional step towards the clinical laboratory and since the resonators are fabricated using 
photolithography, it is amenable to mass producing WGM detection systems.   
 While this approach offers a number of advantages, it is inherently limited by the fabrication 
method, reducing the typical Q-factors attainable to several orders of magnitude lower than 
microsphere-based designs.3  Secondly, each resonator structure must be individually addressed 
through its corresponding grating couplers to record any resonant wavelength shifts; this introduces 
complications when addressing and aligning the excitation and detection system with each resonator.  
Finally, the chemistry involved with functionalization must be performed post-fabrication, which 
introduces major complications.  In order to perform multiplexed detection with this method, the 
immobilization chemistry for each antibody must be performed separately for each individual resonator 
on the chip.  This makes the chemistry involved with planar ring resonators a highly rate-limiting step 
when considering scalability. 
 2.1.4 Resonator Designs:  Advantages and Drawbacks 
 Shown in Table 2.1 is a summary of the current state of microsphere and microfabricated WGM-
based sensor attributes and performance metrics.  Unfortunately, there is a tradeoff inherent to each 
listed approach for WGM detection.  As shown in Table 2.1, microsphere sensors exhibit the best limits 
of detection and are inexpensive.  In addition, they are commercially available, come in various sizes and 
materials, and may be functionalized in batch processing which makes final assay designs flexible and 
Design Attributes Microsphere Sensors Microfabricated Sensors 
Q-Factor Limits ~1x109 ~1x105 
Limits of Detection ~3x10-7 RIU ~2x10-5 RIU 
Multiplexing Capabilities Very Difficult Moderate 
Fluid Handling Very Difficult Good 
Throughput Poor Moderate 
Cost Excellent Good 
Table 2.1:  Summary of common WGM sensor attributes.3 
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cost effective. To date, however, they have limited multiplexing capabilities and have proven difficult to 
integrate into fluidic systems.   
 Microfabricated resonators, on the other hand, are ideal for mass production since their 
construction is based on scalable photolithography processes.  They are amenable to integration with 
microfluidics systems, so fluid handling is quite effective using these sensors.  However the fabrication 
process inherently limits their maximum attainable Q-factor and range of materials.  In addition, all 
chemistry must be performed on-chip after fabrication, which greatly limits the scalability of the 
technique. 
  Our goal for WGM detection is to combine the favorable attributes from both techniques that 
take advantage of the excellent performance metrics and ease of chemistry associated with microsphere 
resonators, retains the scalability of microfabricated sensors, and provides an easy approach to 
multiplexing WGM detection.   
2.2 Development of a New WGM Technique by Utilizing Fluorescence Imaging 
 Here we present a new whispering gallery mode imaging (WGMI) scheme that uses sensitive 
fluorescence imaging of microsphere resonances to provide multiplexed detection capabilities.  The 
motivation of this research is centered on the development of a sensing technique that is label-free, 
sensitive, and amenable to highly multiplexed detection.  The WGMI approach utilizes an inverted total 
internal reflection (TIR) microscope to evanescently couple light from a tunable diode laser into a field of 
microsphere resonators.  In the field of WGM sensing, all current designs have limitations with respect 
to their multiplexing capacity in large part due to the technique in which the WGM spectrum is 
collected.  Instead of employing a single point detector at the distal end of a tapered fiber or waveguide, 
our goal is to examine the amount of light stored within a microsphere resonator using an imaging 
technique.  As each resonator confines light through multiple total internal reflections within the cavity, 
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the approach takes advantage of the evanescent field created at the microsphere surface when a WGM 
resonance is reached.  Outside of the sphere, the field decreases exponentially with r by:21 | | ∝ 	 [−2 ( − 1) /
λ
]    Equation 2.9 
where ε is the dielectric constant, μ is the magnetic permeability, and λ is the vacuum wavelength.  
While not propagating, this field can still excite fluorophores located near the surface of the sphere.  By 
functionalizing the dielectric surface with a fluorescent dye, therefore, increases in sphere fluorescence 
can be used to detect WGM resonances as shown in Figure 2.4.  This simple idea provides a 
straightforward route for measuring changes in the WGM resonances of large fields of resonators using 
fluorescence imaging detection.  On resonance, a distinctive ring of fluorescence is observed as the 
WGM excites the surface attached dye.  As the wavelength of the tunable diode laser is scanned, 
therefore, the WGM resonance of each microsphere in the field of view is measured from enhanced 
fluorescence, which is imaged from above with an upright microscope.   
The feasibility of biosensing using this approach is demonstrated by detecting two biomarkers of 
ovarian cancer - cancer antigen-125 (CA-125) and tumor necrosis factor-alpha (TNF-α).22-27  Monoclonal 
antibodies specific for CA-125 and TNF-α were attached to 38 μm and 53 μm glass microspheres, 
Figure 2.4:  WGM measurement using fluorescence readout. 
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respectively.  Using the relative intensity of the attached fluorescent marker to track changes in the 
resonant wavelength, linear calibration curves were measured for both antigens.  For CA-125, we 
demonstrate detection limits more than threefold better than commercial ELISA kits.  Using this 
approach, the identity of the detected analyte can be encoded in the sphere size and/or location, 
providing vastly improved multiplexing capabilities.  Moreover, the chemistry associated with attaching 
antibodies to glass beads is well developed and all immobilization procedures are carried out before the 
spheres are deposited onto the substrate surface.  This approach, therefore, vastly simplifies the 
chemistry associated with multiplexing over other WGM techniques.  It also provides a sensitive and 
straightforward approach for multiplexed WGM detection that takes advantage of the superior optical 
properties of microsphere resonators.   
2.3 Materials and Methods 
 2.3.1  Reagents 
Soda-lime glass microspheres were obtained from Mo-Sci Corporation (Rolla, MO).  Anti-CA-125 
mouse monoclonal antibodies (SPM111), 3-aminopropyltriethoxysilane (APTES), glutaraldehyde, bovine 
serum albumin (BSA), and all solvents were obtained from Fisher Scientific (Hampton, NH).  CA-125 
antigen was obtained from a commercially available CA-125 screening kit (Panomics BC-1013).  Anti-
TNF-α antibodies were utilized from a commercial TNF-α screening kit (ESS0001, Fisher Scientific), and 
TNF-α antigen was purchased from Pierce Biotechnology (Rockford, IL).  The amine reactive succinimidyl 
ester of Alexa Fluor 633 was obtained from Invitrogen Corporation (Carlsbad, CA).  CoverWell perfusion 
chambers were obtained from Grace Bio-Labs (Bend, OR).   
 2.3.2 Microsphere Preparation 
The 38 µm  and 53 µm diameter microspheres were separately sonicated in an alconox solution, 
triply rinsed with 18 MΩ water, and rinsed with absolute ethanol.  Each sphere set was placed in a 5% 
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APTES (v/v) solution in toluene and allowed to tumble overnight.  Following amine modification, the 
spheres were rinsed once in toluene and triply washed in absolute ethanol.  Each sphere set was then 
placed in a 6% glutaraldehyde (v/v) solution in PBS and tumbled for 2 hours.  The sphere sets were each 
triply washed in PBS then placed into corresponding antibody solutions in PBS to tumble for 2 hours:  
The 38 µm diameter spheres were incubated in 2 µg/mL anti-CA125 solution while 53 µm diameter 
microspheres where incubated in 2 µg/mL anti-TNF-α.  Following incubation, each sphere solution was 
washed in PBS and labeled with the fluorescent dye, Alexa 633.  Finally, each microsphere set was 
tumbled in a 5% BSA, 5% sucrose (w/v) solution in PBS for 1 hour to block nonspecific adsorption sites.   
 2.3.3 WGM Measurement 
For WGM analysis, spheres were dispersed onto a glass coverslip and placed in a CoverWell 
perfusion chamber containing PBS.  Light was coupled into the spheres using the evanescent wave 
generated with an inverted total internal reflection fluorescence microscope (TIRF-M) (Olympus IX71, 
Center Valley, PA) equipped with a 60x objective (1.45 NA achromat, Olympus).  The output from an 
external cavity diode laser (TLB-6904, New Focus, Santa Clara, CA) is offset on the back aperture of the 
objective to create total internal reflection at the substrate interface.  The diode laser can be tuned from 
632.86 to 633.12 nm with ≤300kHz linewidth.  Fluorescence is collected from above using an Olympus 
10x UMPlanFl (0.3 NA) objective lens, filtered (Thorlabs, Newton, New Jersey), and imaged onto a CCD 
camera (Cascade 650, Roper Scientific, Tuscon, AR).  The laser was scanned using LabVIEW (National 
Instruments, Austin, TX) software and image collection and processing was controlled using Slidebook 
software (v4.2.0.3, Intelligent Imaging Innovations, Denver, CO).  
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2.4 Results and Discussion 
 2.4.1 Experimental Design 
 Here we report a general approach for combining WGM microsphere resonators with 
fluorescence imaging to develop a new approach for the multiplexed detection of analytes.  The general 
approach is outlined schematically in Figure 2.5.  Light from a tunable diode laser with narrow spectral 
linewidth (≤300kHz) is launched into an optical fiber and coupled into an inverted total internal 
reflection (TIR) microscope.  The TIR microscope uses a high numerical aperture (1.45 NA) objective to 
couple light to the substrate surface beyond the critical angle, where total internal reflection takes 
place.28  The associated evanescent field is used to launch light into the microsphere resonators on the 
substrate surface as shown schematically in Fig. 2.5. 
As the excitation wavelength of the diode laser is scanned, the WGM resonance from each 
microsphere in the field of view is detected through fluorescence imaging.  This is accomplished by 
Figure 2.5:  Schematic of the apparatus used to couple WGM excitation with fluorescence imaging. 
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approach.  In these experiments, microsphere resonators were bathed in 18 MΩ water to which 
injections of absolute ethanol were added to increase the surrounding refractive index.29  As seen in Fig. 
2.7, a linear response is observed as expected from the relationship between WGM resonance 
wavelength and refractive index (Eq. 2.1).  The particular calibration plot shown in Fig. 2.7 was measured 
from a microsphere with a Q-factor of ~2x104 and has a measured sensitivity of ~50 nm / RIU 
(refractive index units) and a detection limit of ~2.6x10-5 RIU.  Linear calibration plots such as that 
shown in Fig. 2.7 illustrate the feasibility of using microsphere resonators combined with fluorescence 
imaging for biosensing. 
 2.4.3 Ovarian cancer biomarker detection by WGMI 
Having demonstrated that the WGMI approach is sensitive to changes in the refractive index, 
the specific biosensing capabilities are demonstrated using antibodies specific for biomarkers of ovarian 
cancer.  Two separate assays were performed with microspheres modified with antibodies specific for 
cancer antigen-125 (CA-125) and tumor necrosis factor-α (TNF-α), both implicated in the pathogenesis 
of ovarian carcinoma.22-27  As illustrated in Fig. 2.5, the antibodies are attached to the sphere surface 
along with the fluorescent dye.  Moreover, each antibody is attached to a distinct sphere size, thus 
encoding the analyte identity into the sphere diameter which is easily measured in the imaging 
approach.  Here monoclonal antibodies specific for CA-125 were immobilized on 38 μm spheres while 
antibodies for TNF-α were attached to 53 μm spheres.  
Figure 2.8 plots the shifts in WGM resonant wavelength as CA-125 was injected into the 
perfusion chamber.  A linear shift in the resonant wavelength is observed with a measured CA-125 
sensitivity of ~6 pm / U/mL and detection limit of ~1.5 U/mL.  This detection limit is threefold better 
than the ~5 U/mL detection limit of commercial ELISA kits (Panomics BC-1013).  Also shown in Fig. 2.8 is 
a similar calibration plot for the detection of TNF-α using 53 μm spheres functionalized with monoclonal 
antibodies for TNF-α.  The linear response of TNF-α shown in Fig. 2.8 has sensitivity of ~108 pm / ng/mL 
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The calibration plots shown in Fig. 2.8 demonstrate the specific detection of biomarkers using 
the WGMI approach.  Coupling WGM resonators with sensitive fluorescence imaging offers many 
advantages for the multiplexed detection of biomarkers.  The approach is label-free, sensitive, and 
rapid.  Since the analyte identity is encoded in the sphere size or location, every sphere can be labeled 
with the same dye and excited with the same laser system.  Since the WGM resonance wavelength is an 
intrinsic property of the system, the assay does not suffer from complications arising from dye 
photobleaching or variable labeling.  Microspheres are readily available, inexpensive, come in a range of 
materials and sizes, and have extremely large Q-factors which are desirable for sensing applications.  
Finally, their small size makes them compatible with many of the developments taking place in the lab-
on-a-chip field, which can further reduce assay costs.   
2.5 Conclusions 
Fluorescence imaging is combined with total internal reflection excitation of whispering gallery 
modes in resonators to develop a new approach for multiplexed biosensing.  In this approach, 
microspheres are functionalized with a fluorescent dye that acts as a reporter of the WGM resonance.  
Light is coupled into a field of microspheres using the evanescent field created in a total internal 
reflection microscope.  As the excitation wavelength is scanned, WGM resonances are detected through 
fluorescence imaging.  As a particular sphere reaches a WGM resonance, a distinct ring of enhanced 
fluorescence is observed as the evanescent wave from light circumnavigating the sphere excites the 
surface attached dye.  This approach enables the simultaneous measurement of WGM resonances from 
every microsphere in the field of view, thus enabling the development of highly multiplexed biosensors. 
To demonstrate the feasibility of biosensing using the WGMI approach, antibodies specific for 
CA-125 and TNF-α were linked to 38 μm and 53 μm spheres, respectively.  CA-125 and TNF-α are 
commonly used markers for the screening of ovarian cancer and by linking their antibodies to 
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differentially sized microspheres, detection specificity is encoded into sphere diameter.  Binding of their 
associated antigens shifts the WGM resonance of the sphere, which is detected using fluorescence 
imaging.  Calibration curves measured in separate assays reveals a linear response for both antigens 
with the detection limits for CA-125 over threefold better than that obtained with commercial ELISA 
approaches.  These results confirm that fluorescence imaging can be used to simultaneously detect 
WGMs from a field of microsphere resonators where analyte identity can be encoded into sphere size 
and/or location, thus enabling significant multiplexing capabilities.   
The major drawback associated with this approach is the method of excitation.  Using a TIRF 
microscope for excitation introduces a considerable degree of cost to the instrumental design.  Also, 
since a high-NA objective must be used, the field of view is limited and the coupling efficiency into the 
resonators is poor.  The small region can excite only a limited number of resonators simultaneously, 
presenting scalability challenges using the TIR microscope.  In addition, these studies were performed in 
buffer systems, and as with any viable screening method, the approach must be amenable for use in 
clinical serum samples.  To address these issues, Chapter 3 will discuss instrumental modifications to 
increase the multiplexing ability of the WGMI technique, and the expansion of the method to measure 
cancer biomarkers present in clinical serum samples. 
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Chapter 3:  Serum Biomarker Quantification Using Whispering Gallery Mode Imaging 
3.1 Introduction 
In Chapter 2, we discussed how fluorescence imaging can be used to track individual WGM 
resonances in glass microspheres.  Using total internal reflection (TIR) microscopy to excite a field of 
microspheres, individual excitation spectra are extracted from fluorescence images collected as the 
wavelength is scanned.  The approach was validated by measuring binding of CA-125 and tumor necrosis 
factor α (TNF-α) in buffer solution using fluorescently labeled microspheres with immobilized 
antibodies.  Here we introduce a simplified method for launching WGMs into labeled microspheres by 
employing a Dove prism; this approach enables much larger fields of spheres to be simultaneously 
excited and imaged.  Using this approach, we demonstrate the simultaneous measurement of WGM 
resonances from over 120 individual microresonators, illustrating the substantial multiplexing 
capabilities afforded by this method.  To advance this technique toward clinical use, we also show that 
non-specific binding is not limiting by detecting CA-125 doped into serum samples.  The eventual clinical 
utility of this approach is illustrated by measuring CA-125 levels in serum collected from a healthy donor 
and a patient diagnosed with ovarian cancer. 
Through changes in the instrumental technique, the increased signal from microsphere 
resonators has revealed that the underlying mode structure within each cavity can be imaged.  Imaging 
these patterns provides an opportunity to track analyte binding through changes in mode structure 
which would simplify the WGM imaging method even further.  We introduce finite element analysis as a 
way to assist in exploring resonator geometries and conditions which optimize sensor performance, and 
discuss initial work using simulations which could eventually relate fundamental mode structure to 
observed patterns. 
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3.2 Materials and Methods 
 Barium-titanate glass microspheres were obtained from Mo-Sci Corporation (Rolla, MO).  Anti-
CA-125 mouse monoclonal antibodies (X75) were purchased from Abcam (Cambridge, MA).  CA-125 
ovarian tumor marker antigen was obtained from MP Biomedicals (Solon, OH) and used without further 
purification.  The amine reactive succinimidyl ester of Alexa 633 fluorescent dye was obtained from 
Invitrogen Corporation (Carlsbad, CA), and perfusion chambers were obtained from Grace Bio-Labs 
(Bend, OR).  Clinical human serum samples were acquired from Proteogenex Inc. (Culver City, CA). 
StartingBlock blocking solution was obtained from Thermo Pierce Products (Rockford, IL), and all other 
reagents, unless otherwise noted, were purchased from Fisher Scientific (Hampton, NH) and used 
without further purification.  
 To prepare the spheres for use in a WGM assay, 53μm diameter barium titanate microspheres 
were soaked in a 10% Contrad 70 solution in 18MΩ nanopure water for 1h and triply rinsed with 
nanopure.  The spheres were then incubated in 30% hydrogen peroxide solution for 1hr to increase the 
number of hydroxyl groups on the surface.1  After triply rinsing with nanopure water, ethanol, and 
toluene, the spheres were tumbled overnight in 6% APTES in toluene, and triply rinsed in toluene and 
ethanol to form an amine terminated surface.  To attach antibodies to the spheres, samples were 
subsequently tumbled for 2hr in 6% glutaraldehyde solution in PBS and triply rinsed with PBS, then 
incubated overnight with anti-CA-125 mouse monoclonal antibodies overnight to immobilize the 
capture agent on the sensor surface.  The microspheres were triply rinsed with PBS and labeled with 
Alexa 633 fluorescent dye.  In order to block nonspecific adsorption sites, the spheres were tumbled for 
2hr in a StartingBlock solution containing 5% BSA, 5% sucrose (w/v %) and refrigerated until used. 
 To perform WGM measurements on the prepared samples, microsphere resonators were 
deposited into PDMS wells adsorbed to glass coverslips and enclosed in a CoverWell perfusion chamber, 
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and subsequently immersed in a 1:1 solution of PBS:serum.  Coverslips were attached to an uncoated 
BK7 Dove prism (Edmund Optics, Barrington, NJ) and mounted onto a three-axis robotic 
micromanipulator (MP-285, Sutter Instruments, Novato, CA).  Light from an external cavity diode laser 
(TLB-6904, Newport Corporation, Irvine, CA) was free space coupled into the Dove prism resulting in 
total internal reflection, forming an evanescent wave at the center of the prism for coupling light into 
the resonators.  Fluorescence was collected from above the sample with an upright microscope 
(Olympus BXFM, Center Valley, PA) equipped with a 10X UMPlanFL (0.3 NA) objective lens (Olympus), 
filtered (Thor Labs, Newton, New Jersey), and imaged on a CCD camera (Cascade 650, Roper Scientific, 
Tuscon, AR).  Diode laser wavelength was controlled using LabVIEW (National Instruments, Austin, TX) 
and image collection and processing was performed with SlideBook software (Version 4.2.0.3, Intelligent 
Imaging Innovations, Denver, CO). 
3.3 Results and Discussion 
3.3.1 Incorporating Dove Prism Coupling Into Whispering Gallery Mode Imaging 
In Chapter 2, we demonstrated the fluorescence imaging of WGM resonances using the 
evanescent field from a total internal reflection (TIR) microscope to launch into a field of dye labeled 
microspheres.  The high numerical aperture (1.45 NA) objective needed to create the TIR field, however, 
limited the number of microspheres that could be simultaneously excited, increased the cost of the 
apparatus, and lowered the coupling efficiency of excitation into the microresonators.2  Here we show 
that the much simpler arrangement shown schematically in Fig. 3.1 overcomes these drawbacks.  As 
shown in Figure 3.1, excitation from a computer controlled tunable diode laser is sent into a Dove prism 
which directs light towards the substrate surface beyond the critical angle.  This creates an evanescent 
field which is used to couple light into a field of microsphere resonators.  By imaging the sample from 
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above, fluorescence excited from light stored within the microresonators is collected and detected in a 
similar manner as discussed in Chapter 2. 
3.3.2 Highly Multiplexed Microsphere WGM Excitation 
Figure 3.2 shows a representative fluorescence image from a field of microsphere resonators 
mounted on a Dove prism.  The 868 μm x 654 μm field of view contains over 120 microspheres with 
mixed diameters of 53 μm and 63 μm.  The microspheres exhibit a ring of fluorescence as light 
Figure 3.1:  Schematic of the instrumental arrangement used for fluorescence imaging of WGM 
resonances in a field of microsphere resonators incorporating Dove prism excitation.   
Figure 3.2:  Snapshot of a size mix of fluorescently labeled microspheres mounted on a Dove 
prism undergoing WGM excitation. 
  47 
 
circumnavigating within the sphere excites the surface attached dye through the associated evanescent 
field.  While the fluorescent stripe around most spheres appears weak, a few spheres show particularly 
strong fluorescent stripes.  These microspheres have WGM resonances near the excitation wavelength 
used to collect this image.  As the excitation wavelength is scanned, different spheres come in and out 
of resonance which is easily tracked in the fluorescence imaging approach. 
3.3.3 Sensor Validation and Characterization of Nonspecific Adsorption 
In Chapter 2 we demonstrated that fluorescence imaging of WGM resonances can quantify the 
presence of the ovarian cancer marker CA-125 in buffer solutions.  Here we extend those measurements 
to CA-125 detection in serum samples, where nonspecific interactions can play a more important role.  
Label-free detection schemes, like the one developed here, are generally susceptible to interference 
signals arising from non-specific binding.3  These can be problematic for label-free approaches and often 
pose a significant challenge in developing new sensing schemes.  In order to reduce nonspecific 
interference, a number of blocking approaches were utilized to test our WGM sensors’ response 
following serum additions.  To examine the effects of non-specific binding, the response of two 
microsphere resonators were compared with one another – one microsphere was labeled with dye and 
blocked using the approach outlined in section 3.2, while the other was labeled with dye but received no 
further treatment.  The spheres were immersed in PBS and exposed to additions of human serum into 
the perfusion chamber.  The spectral response of each sensor is illustrated in Figure 3.3.  As seen in 
Figure 3.3, the blocked spheres (A) exhibit a linear red-shift in sensor response due to serum injections 
in PBS.  Since the refractive index of human serum is greater than the PBS immersion medium, the bulk 
refractive index surrounding the resonator increases with each injection, resulting in a linear red-shift in 
the resonant wavelength, similar to the refractive index assay seen in Fig. 2.7.  What is important in this 
graph is the lack of a nonlinear spike in the resonant wavelength, which would be indicative of a large 
degree of nonspecific protein binding, indicating that matrix effects due to human serum have been 
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structure is reflective of the underlying electromagnetic fields confined in the dielectric, and gives us a 
new approach for directly measuring whispering gallery mode structure.  One advantage afforded by 
this phenomenon is the possibility of exploiting these patterns for new approaches to quantify refractive 
index changes or to track analyte binding.  Using this property for sensing would be advantageous as the 
high resolution laser system used to measure the narrow WGM resonances would no longer be needed.  
Moreover, analyte quantification from mode structure measurements would greatly reduce the 
complexity of instrumentation used for point-of-care screens. 
To examine mode structure response to refractive index changes, the series of images shown in 
Fig. 3.7 are far-field fluorescence images of a sphere taken as the surrounding refractive index is 
increased.  It is apparent in Figure 3.7 that the mode structure is altered as refractive index is increased, 
and could therefore be used for sensing purposes.  The complex patterns seen are likely due to the 
interference of several modes excited in the resonator; multiple WGMs can be excited simultaneously 
since both the Q-factor of the sphere is finite, as is the bandwidth of the excitation source.5  To exploit 
this property for sensing, future goals include using the banding patterns to create an image recognition 
algorithm calibrated by known refractive index standards.  Post-calibration, an immunoassay would then 
be performed and target analyte concentration would be calculated using the calibrated algorithm.  
These measurements could result in a new direction for WGM sensor development that would obviate 
Figure 3.7:  Mode structure changes in response to increasing refractive index. 
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the need for a high resolution laser system and enable the development and implementation of WGM 
sensors and assays using inexpensive conventional laser sources. 
  3.3.6 WGM Modeling Using Finite Element Analysis 
One possible approach to interpret simple patterns formed from the mode structure seen in the 
previous section is through finite element analysis.  The simulation program, COMSOL Multiphysics, has 
shown promise in simulating the EM fields in WGM resonances; a simplified example of this modeling 
process is shown in Figure 3.5. The geometry is first defined with a high-index circular structure encased 
in low-index surroundings, seen at left in Fig. 3.5.  While our sensors are spherical, our initial studies 
reduce the problem to two dimensions for simplicity – future studies will incrementally work toward a 
full three-dimensional model of our system.  After building the model, it is broken down into discrete, 
finite elements in a meshing process, seen in the center panel of Fig. 3.5.  By solving Maxwell’s 
equations for EM fields within the resonator, solutions can provide insight into simple WGM resonances. 
The right panel of Fig. 3.5 shows the simulated resonance of a 15μm diameter barium titanate cylinder 
in air with = 16 (see Eq. 2.1).  While these simulations are relatively easy to perform on simple 
geometries, scaling this process to the dimensions of our current experiment must be performed 
incrementally.6, 7  Using this information, a pattern recognition algorithm may eventually be developed 
to correlate resonator mode structure changes with analyte binding. 
Figure 3.8:  COMSOL model construction, meshing, and simulation of a simple WGM resonance. 
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3.4 Conclusion 
A simplified method for launching WGMs into labeled microspheres by employing a Dove prism 
is introduced which enables much larger fields of spheres to be excited and imaged.  We demonstrate 
the large multiplexing potential of this fluorescence approach by imaging over 120 microsphere 
resonators in an area less than 1 mm2.  To advance this technique toward clinical use, we also show that 
non-specific binding is not limiting by detecting CA-125 doped into serum samples.  Linear calibration 
plots of sensor response with CA-125 levels were collected in 1:1 PBS:serum solutions, suggesting that 
non-specific interactions can be sufficiently minimized using standard blocking protocols.  The 
immunoassay displayed a linear response with a sensitivity of ∼1.8 pm / U/mL and limit of linearity of 
∼10 U/mL CA-125.  The measured detection limit of ∼1.8 U/mL is more than a factor of two better than 
commercial ELISA detection of CA-125.8  Finally, we demonstrate the clinical utility of this approach by 
quantifying the CA-125 levels in a serum sample collected from an ovarian cancer patient diagnosed 
with stage II adenocarcinoma and compare that with levels measured in serum from a healthy donor.  
The measured CA-125 level in the healthy donor was ∼42 U/mL, consistent with general baseline value 
of ∼35 U/mL expected for healthy women.  The measured CA-125 level in the cancer patient, however, 
was ∼316 U/mL, nearly an order of magnitude higher than the normal baseline level and indicative of 
ovarian cancer pathogenesis.  These results illustrate the utility of using fluorescence imaging of 
whispering gallery modes to quantify biomarkers in complex biological media.  The large multiplexing 
potential of this label-free approach is of particular interest as the discovery of new biomarkers 
continues to expand. 
Through changes in the instrumental technique, we demonstrate that the increased signal from 
microsphere resonators can be used to image the underlying mode structure within each cavity.  
Imaging these patterns provides an opportunity to track analyte binding through changes in mode 
structure which would simplify the WGM imaging method even further, potentially removing the 
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necessity of using high-resolution laser sources for WGM sensing.  We also introduce using finite 
element analysis to assist in exploring resonator geometries and conditions which optimize sensor 
performance, and discuss initial work using simulations which could eventually relate fundamental 
mode structure to observed patterns. 
 As in all label-free assays, non-specific effects remain a concern for WGM detection and it is 
highly desirable that all immobilized antibodies be active.  Despite the long historical development in 
immunoassay technology, however, immobilization protocols for antibodies remain surprisingly 
inefficient, often resulting in the amount of active immobilized antibody to less than 10-20%.9-11  This 
obviously has deleterious effects on any immunoassay, but is particularly problematic with the WGM 
imaging method since the sensing region of our microsphere WGM resonators is restricted to a small 
area surrounding their equator.  Moreover, if we consider the mode structure within the cavity, this 
further reduces the surface area sensed by the circulating light (see Fig. 3.9). 
 
Figure 3.9:  Microsphere WGM displaying mode structure. 
These operational constraints place strict demands on the quality of the immobilized antibody sensing 
layer.  It is well known that the orientation of immobilized antibodies is directly related to their binding 
efficiency.  Antibodies oriented improperly may have their recognition site blocked, reducing sensor 
performance.  The techniques employed to determine immobilized antibody orientations, however, 
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generally rely on indirect measurements and often simply correlate good assay performance with good 
orientation.  Clearly, new methods are needed which can directly probe antibody orientation, 
specifically at single molecule levels.  A technique capable of these measurements would help 
determine attachment protocols that optimize antibody activity, thus maximizing immunosensor 
performance.  The following chapters are devoted to developing and validating an emerging 
fluorescence-based approach for determining the three-dimensional orientation of single molecules to 
obtain structural information in biological systems at the molecular level.  Before these measurements 
can be applied to antibody systems, however, the fluorescence technique must first be validated in a 
well-controlled test system.  The following chapters discuss the development of this technique, with the 
eventual goal of optimizing immobilization protocols to maximize antibody performance. 
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Chapter 4:  Antibody Immobilization Techniques and the Introduction of a Test System for 
Orientation Measurements at the Single Molecule Level 
4.1 Antibody Efficiency Due to Preparation Procedures 
 In immunoassay design and execution, the crux of the technique relies on an antibody-antigen 
interaction.  Commonly, the antibody is first immobilized on a substrate surface which can significantly 
impact both the orientation and the function of the antibody and can ultimately define how efficient an 
assay performs.  Immobilization procedures strive to bind antibodies with their active site exposed to 
maximize binding efficiency.  An example of antibodies bound in both random and directed orientations 
is illustrated schematically in Figure 4.1.  Since the quality of the assay depends on efficient antibody-
antigen binding and the diagnostics industry relies so heavily on immunoassay technology, there is 
considerable interest in developing immobilization procedures which maximize these interactions.  
Understanding the orientation of bound antibodies in situ and relating this information to assay 
efficiency is crucial for improving both the label-free techniques discussed in Chapters 2 and 3 and all 
capture techniques which rely on antibody-antigen interactions. 
Figure 4.1:  Directed and random antibody configurations.1 
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 4.1.1 Antibody Immobilization Methods 
 The approaches used for antibody immobilization can be broadly grouped into three categories:  
adsorption, covalent binding and specific interaction-based methods.  The most common immobilization 
techniques within these broad categories are outlined in Table 4.1.  Out of all approaches listed, 
nonspecific adsorption approaches offer the quickest route to antibody immobilization.  Many multi-
well plate-based ELISA techniques employ the adsorption technique in plastic wells without 
pretreatment, making this approach appealing since there is little labor involved.  Unfortunately, the 
adsorption method inherently results in random antibody orientations.  In addition, the antibodies are 
bound only by electrostatic interactions, so certain buffer conditions will result in desorption and thus 
loss of activity.  Since this approach offers no control over antibody orientation, it is a poor choice to 
employ for assays requiring maximal antibody performance as binding efficiencies for random 
orientations is generally ~10%.2, 6, 7 
Immobilization Method Surface Chemistry Attachment Site Advantages Disadvantages 
Adsorption 
Agarose 
Polyacrylamide 
Nitrocellulose 
Poly-L-lysine 
Amino 
Nonspecific 
Binding 
Easy to 
perform. Random orientations. 
Covalent Binding 
Maleimide 
Hydrazine 
Succinimidyl Ester 
Epoxide 
Aldehyde 
 
Thiol 
Carbohydrate 
Amine 
Amine 
Amine 
 
Stable 
binding & 
easy to 
perform. 
Antibody pretreatment 
sometimes needed. 
Random orientations 
occasionally. 
Affinity Based 
Protein A/G 
Streptavidin 
Cellulose 
Nickel 
Copper 
Glutathione 
Fc Region 
Biotin 
CBM* 
Histidine Tag 
Histidine Tag 
GST Tag 
Directed 
orientation. 
Must be used for specific 
antibody classes.  Labor-
intensive, and long-term 
stability problems 
*CBM – Carbohydrate Binding Molecule    
Table 4.1:  Common Ab immobilization approaches and their attributes, adapted from Ref 1, 2.
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 Covalent approaches are slightly more labor intensive but are still considered easy to perform.  
Since the antibody is covalently bound to the substrate surface, this method is the most stable approach 
to immobilization.  The drawbacks to this technique are that some methods require additional 
modification of the antibody which can result in loss of function, and binding can attach to numerous 
functional groups on the structure, often resulting in randomly oriented antibodies and again reducing 
efficiency to ~10%.2, 6, 7  
 Affinity-based methods currently provide the greatest degree of orientation control, with 
antibody-antigen binding efficiencies reported to be as high as ~83%.8  This approach employs natural 
proteins and engineered materials to bind antibodies in a designed to expose their active region for 
near-maximum binding efficiency.  The drawbacks associated with this technique are that it is quite 
labor intensive and the stability of the macrostructure is much less robust than that obtained through 
covalent binding.  Ion screening in some buffer conditions can cause these complexes to break down, 
and long-term storage capabilities are difficult as compared with other techniques.2, 6, 7 
 While considerable work is being invested in finding the most efficient antibody immobilization 
procedure, there is a need for techniques capable of measuring the resulting orientation of the 
immunogen.  This information can be used to fine-tune immobilization protocols to maximize antibody 
activity in immunoassay design. 
 4.2 Common Methods Used to Measure Antibody Efficiency and Orientation 
 As mentioned in the previous section, proper orientation of the antibody is crucial for efficient 
immunoassay performance.  Just as there is a substantial amount of effort directed towards antibody 
immobilization techniques, there are numerous techniques which are utilized to approximate antibody 
orientation.  An overview of these methods and their attributes is outlined in Table 4.2. 
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 4.2.1 Antibody Binding Measurements 
 In antibody binding measurements, the orientation is inferred through the efficiency of binding 
in immunoassays, simply correlating good signal with good orientation.  These techniques, however, 
cannot distinguish between antibody orientation and degree of denaturation due to the immobilization 
process.  The methods can determine which immobilization procedures result in higher instrumental 
response, but provide no information regarding antibody orientation. 
 4.2.2 Microbalance Measurements 
 Microbalance approaches approximate antibody orientation through mass loading by making a 
broad assumption that the antibody distribution is homogenous.  Like the above measurements, this 
technique cannot discern between denatured or differentially oriented antibodies.  As discussed 
previously, nonspecific adsorption and covalent binding often result in randomly oriented antibodies, 
rendering this technique incapable of measuring antibody orientations. 
Technique Mechanism Advantages Disadvantages 
Antibody Binding 
Measurements9, 10 
(Numerous) 
Comparison of instrument 
response (SPR, ELISA 
turnover, fluorescence 
intensity, etc.) to different 
immobilization strategies. 
Generally easy to 
perform  
Can only assume 
orientation.  No direct 
information provided. 
Microbalance11, 12 
Mass measurement 
(approximates orientation via 
antibody loading) 
Straightforward 
Assumes homogenous 
antibody distribution.  
Cannot distinguish Fab-up 
versus Fab-down. 
AFM*13, 14 Topographically infers orientation 
Effective at 
approximating 
numerous 
orientations. 
Very difficult in liquid 
samples.  Poor 
throughput. 
TOF-SIMS**15 
Amino acids exposed to outer 
surface are compared to 
known sequence. 
Has promise in 
directly observing 
Ab orientation. 
Extremely difficult.  Must 
be performed in dry 
samples (ex situ). 
Neutron Reflection14, 
16 
Measures protein density as a 
function of surface distance. 
Can use information 
to infer absolute 
protein orientation 
Difficult and expensive.  
Cannot directly probe 
orientations. 
*AFM – Atomic Force Microscopy 
**TOF-SIMS – Time-of-Flight Secondary Ion Mass Spectrometry  
Table 4.2:  Instrumental techniques used to measure antibody orientation. 
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 4.2.3 AFM Studies 
 Atomic force microscopy uses topographical features to approximate orientation by visualizing 
the domain structure and height differences formed from immobilized antibodies.  While this technique 
can provide some degree of information regarding antibody orientation, the information it provides is 
often quite ambiguous and difficult to interpret.  In addition it has extremely low throughput and is 
difficult to perform in aqueous samples, making in situ measurements problematic. 
 4.2.4 Time-of-Flight Secondary Ion Mass Spectrometry 
 In TOF-SIMS, an antibody-functionalized substrate is bombarded with an ion source and the 
chemical profile of ejected amino acid secondary ions is compared to a known sequence of the 
immobilized immunogen.  While this technique has shown promise in determining the orientation of 
surface bound antibodies, it is highly complex, expensive, and must be performed on dry samples in 
vacuum.  This is a substantial drawback, as method is not amenable to probing antibodies in relevant 
buffered solutions, and introducing the substrate to such conditions may result in antibody 
denaturation.  The TOF-SIMS approach is therefore ill-suited for our goals. 
 4.2.5 Neutron Reflection 
 This technique measures the degree of neutron reflection with respect to distance from a target 
substrate.  Using this method, the protein density versus surface distance can be used to approximate 
antibody orientation in a sample.  The drawback with this method is that it is both difficult to perform 
and expensive in practice.  In addition, this technique is based on ensemble averaged measurements, 
and therefore may average heterogeneous behavior, which is again an issue for random antibody 
orientations. 
 4.2.6 Probing Antibody Orientation 
 The previous sections provide a brief overview of the methods currently employed for inferring 
antibody orientation on substrate surfaces.  Most of these methods cannot directly determine antibody 
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orientations, but generally correlate good activity with proper orientation based on immunoassay 
performance.  In addition, most of these methods rely on information gathered from bulk 
measurements.  This ensemble averaging can miss heterogeneous behavior such as domain formation in 
substrate bound antibody systems.  As most antibody immobilization approaches result in random 
attachment, averaging techniques would fail to discern the full distribution of antibody orientations. 
 Clearly, a new approach is needed which can directly measure antibody orientation and 
correlate this information with immobilization protocol.  The method must be capable of obtaining all 
molecular orientations within the system independently in order to capture any heterogeneous 
behavior.  In addition, the method must have the ability to perform these measurements both in situ 
and without disturbing the immobilized antibodies.  We therefore must explore a new approach to 
probe molecular orientation free from ensemble averaging. 
4.2 An Emerging Fluorescence Approach for Measuring Molecular Orientations 
 Previously it has been shown that an emerging 
fluorescence technique can measure the three-dimensional 
orientation of single-molecule reporter probes.  This 
technique provides a unique opportunity to directly probe 
molecular orientations in model and biological systems.  
Consider a beam of light impinging on an interface between 
a medium of high refractive index and a medium of lower 
refractive index as illustrated in Fig. 4.2. When the incident 
angle increases beyond the critical angle, θc, light is no 
longer refracted into medium n2, but is totally internally 
reflected back into medium n1.  While the light beam is totally reflected into medium n1, an 
exponentially decaying evanescent wave is still produced which extends into the medium of lower 
Figure 4.2:  Light incident upon a refractive 
index-mismatched boundary.  
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refractive index.  This field may be utilized in 
microscopy to excite fluorescent markers close to 
the imaging surface and has been employed as a 
background reduction method since the evanescent 
tail reaches only hundreds of nanometers above the 
surface.17, 18  An example of the geometry employing 
total internal reflection fluorescence microscopy 
(TIRF-M) is illustrated in Figure 4.3. In this setup, 
laser light is directed into a high numerical aperture 
objective lens.  If the excitation beam is offset from 
the center of the back aperture of the lens, the 
incident angle on the substrate is increased.  As this 
offset progresses, TIR is eventually reached and an 
evanescent field is produced at the sample 
surface.  Resulting fluorescence from reporter 
molecules on the substrate are collected in an 
epifluorescence fashion and imaged onto a 
detector array.  The field has progressed to a point 
where the fluorescence from single molecules can 
easily be measured.  An example of this capability 
is shown in Figure 4.4.  Each Gaussian feature in 
the image represents the fluorescence from a 
single fluorophore, showing the high signal-to-
noise ratio capable using this approach.   
Figure 4.3.  Fluorescence microscopy employing 
total internal reflection.3 
Figure 4.4:  Fluorescence microscopy image of single 
molecule fluorophores in focus. 
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Figure 4.5:  Schematic representation of emission dipoles oriented 
parallel and perpendicular to a glass interface.3 
 
 Several groups have shown that polarized total internal 
reflection fluorescence microscopy (PTIRF-M) can be used not 
only to image single molecules but capture their three-
dimensional orientation in the sample.19-23  When in free space, 
the emission dipole of a single molecule emits light in a sine 
squared pattern, illustrated schematically in Figure 4.5.   If this 
emission dipole is brought near an interface that is refractive 
index mismatched, however, this emission pattern gets 
distorted as it is coupled into the interface.  An example of this distortion is illustrated in Figure 4.6.  The 
key feature of the radiation patterns shown in Figure 4.6 is that parallel and perpendicular emission 
dipoles couple emission into the collection optics at different angles.  This shows that the orientation of 
single fluorophores will affect 
how fluorescence is coupled 
into the imaging optics.  
However, as seen in the 
microscopy image in Figure 
4.4, single molecule 
fluorescence images produce 
Figure 4.5:  Fluorescence emission 
in free space, with the emission 
dipole indicated by the arrow.
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Gaussian emission profiles as light from all collection angles is brought to the same focal point.  In order 
to capture the emission dipole information, spherical aberrations must be introduced into the optics 
train.   These aberrations arise when light coupled into the periphery of an objective is not focused to 
the same point as light coupled into the center of 
the lens, an example of this is seen in Figure 4.7.  In 
an instrumental setup, spherical aberrations will 
cause light entering the objective at different 
angles to ultimately be focused onto different 
regions of the detector array.  Imaging single 
molecule fluorescence with spherical aberrations 
introduced into the collection optics, therefore, will 
produce intensity patterns on the detector array 
that reflect the emission dipole 
orientations.  Experimentally, the most 
straightforward way to introduce these 
aberrations is by defocusing the collection 
optics ~500nm.  An example of a single-
molecule fluorescence image where 
spherical aberrations have been 
introduced is seen in Figure 4.8.   As 
shown in Figure 4.8, a variety of emission 
patterns are observed in the 
Figure 4.8:  Single molecule image collected using out-of-
focus PTIRF-M.  The anisotropic fluorescence emission of the 
reporter molecule leads to the observed patterns.
Figure 4.7:  Example of spherical aberrations, 
where light passing through the periphery of 
the lens is focused to a different point than 
light passing through the lens’ periphery. 
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Figure 4.10:  Polar coordinates used 
for assigning molecular orientations. 
fluorescence image.  The pattern circled in red exhibits a donut-like shape which corresponds to an 
emission dipole oriented perpendicular to the collection surface. This pattern results from emission 
collected at high angles as seen in Fig. 4.5.  The 
emission pattern circled in yellow exhibits a wing-
like shape, with a greater intensity in the center 
and weaker fluorescence observed on the edges of 
the feature.  This pattern corresponds to an 
emission dipole oriented parallel with the imaging 
surface where most of the fluorescence intensity is 
collected at low angles as seen in Fig. 4.5.  These 
emission patterns can therefore be used as a 
marker for molecular orientation.  By comparing 
collected information to calculated data, any 
arbitrary orientation can be discerned using this 
method.  An example of this type of comparison 
can be seen in Figure 4.9.  The tilt of the emission 
dipole away from the surface normal is termed 
the polar (Φ) angle, and the rotation about its axis the 
azimuthal (θ) angle.  A graphic representation of this 
convention is shown in Figure 4.10. 
 In order to probe fluorophores at any arbitrary 
orientation, the evanescent wave must have a field which 
can excite all possible orientations of the absorption 
dipole with respect to the substrate surface.  This is 
Figure 4.9:  At left are experimentally collected single 
molecule emission patterns.  Comparison of these 
patterns with simulated data at center allows for the 
calculation of the three-dimensional orientation 
listed which is shown schematically at right.4 
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achieved through utilizing p-polarized light in TIRF-M; a representation of the evanescent wave 
produced from this type of excitation is shown in Figure 4.11.  In Fig. 4.11, the electric field (red) from p-
polarized light produces a “cartwheel” type effect when undergoing total internal reflection, enabling 
the excitation of any arbitrary fluorophore orientation.  
 This fluorescence approach enables the three-dimensional orientation of single molecules to be 
directly measured.  By doping fluorescent probes into substrate supported systems therefore, the 
structural properties of these systems can be measured at the molecular level.  Before applying the 
technique to immobilized antibody systems, however, this fluorescence method must first be validated 
in a well-characterized test system where molecular level structure is known and can be controllably 
changed.  An ideal system for validating this approach includes the use of monolayer lipid membranes 
fabricated using Langmuir-Blodgett deposition.  This technique enables precise control over the 
molecular structure of deposited films, and is well-suited to test and characterize the single-molecule 
fluorescence technique.   
 
Figure 4.11:  Schematic illustration of p-polarized total internal reflection.3 
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4.3 Langmuir-Blodgett Membrane Deposition 
 The Langmuir-Blodgett process allows for the precise control and deposition of lipid films on 
target substrates and thus provides an excellent system for exploring the effects of composition, 
temperature, and surface pressure on membrane systems.24, 25  In this technique, amphipathic lipids are 
dissolved in a volatile solvent then deposited onto a water subphase as seen in Figure 4.12.  The polar, 
hydrophilic headgroups are solvated by water molecules in the subphase and the nonpolar acyl tails are 
pushed out of the aqueous phase due to hydrophobicity, leaving the lipid molecules trapped at the air-
water interface.  The tendency of the lipids to spread on the subphase is countered by a movable 
barrier.  As the barrier is compressed it reduces the area of each lipid molecule, causing an increase in 
surface pressure of the monolayer confined to the subphase surface.  The lipids can be compressed to a 
specified surface pressure and deposited evenly onto a substrate using a dipping mechanism.  This 
ability to alter the surface pressure of the monolayer allows for precise thermodynamic control of the 
model system. 
 The test system we will employ for exploring the single molecule orientation measurements 
involves the amphipathic molecule dipalmitoylphosphatidylcholine (DPPC), a phospholipid which is a 
Figure 4.12:  Schematic illustration of a Langmuir-Blodgett (LB) trough. 
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respectively, as the dye entropically partitions into the liquid-expanded region.  As the monolayer is 
further compressed, the lipid molecules become tightly packed and exist in a highly ordered state 
dominated by the LC phase.  Further compression leads to a solid-condensed (SC) phase before the 
monolayer eventually buckles and collapses into the subphase.  Using the LB technique, therefore, 
monolayers can be deposited at any point along the pressure/area isotherm, thus allowing for very 
precise control of membrane structure at the molecular level. 
 LB monolayers of DPPC will serve as initial our test system to validate the single-molecule 
approach.  A fluorescent lipid analog, BODIPY-PC, is doped into DPPC films at trace amounts.  Previous 
studies have shown that this probe preferentially partitions into the less ordered phases present and has 
been used extensively in phase partitioning studies such as that shown in Fig. 4.14.5, 26  For the single 
molecule studies, BODIPY-PC will serve as the reporter molecule as it is structurally similar to DPPC and 
contains its fluorophore in the acyl chain region of the lipid, where its orientation is most susceptible to 
changes in membrane structure.  Through measuring the emission patterns of this reporter molecule as 
a function of surface pressure, we can use their orientations as a measure of molecular order in the 
system.  The following chapters encompass the validation of the single-molecule approach through 
studying model membrane films as a function of surface pressure, additive concentration, and 
atmospheric conditions.  Future goals for this technique include the direct measurement of immobilized 
antibodies to measure and subsequently optimize the efficacy of preparation protocols. 
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Chapter 5: Exploring the Effects of Sterols in Model Lipid Membranes using Single-
Molecule Orientations 
 
As mentioned in Chapter 4, a well-characterized test system is needed for properly 
examining and developing the single-molecule orientation approach.  LB films of lipids provide 
an ideal platform for these studies since these systems have been thoroughly characterized and 
enable a high degree of systematic control over the molecular level structure.  This chapter will 
discuss the motivation for utilizing a simplified model system in single-molecule fluorescence 
measurements, and how these measurements can be used to characterize the molecular 
structure present in model membrane systems.  The effects of thermodynamic properties and 
additives are also used to compare monolayer and bilayer membrane systems using this 
approach. 
5.1 Introduction 
The complexity of biological membranes often makes direct studies of membrane 
properties difficult in intact tissues.  The number and distribution of membrane components is 
highly variable and not easily controlled, complicating both the experimental approaches and 
interpretation of the resulting data.  These difficulties have led to the development of model 
membrane systems, using both lipid monolayers and bilayers.  These simplified models provide 
much more control over parameters such as membrane composition, but questions remain 
regarding their utility in understanding the vastly more complex natural biomembranes.  
Regardless, it is clear that these model systems have been invaluable for understanding, for 
instance, the phase behavior of lipid films and the physical effects of membrane additives such 
as cholesterol.   
Bilayers formed from vesicle fusion onto substrates provide a conceptually appealing 
mimic of biomembranes while monolayers fabricated using the Langmuir-Blodgett (LB) 
technique offer the advantage that the surface pressure can be precisely controlled.  In the LB 
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technique, the propensity of lipids to spread at the air-water interface is countered by an 
external mechanical pressure provided by a moving barrier.  This enables the precise 
measurement and control over film lateral surface pressure (Π) which is the first derivative of 
free energy with respect to surface area.  These measurements, therefore, provide a direct link 
between surface pressure and film thermodynamics which can be studied over a wide range of 
pressures, temperatures and film compositions.   
For model bilayers, surface pressure is not well defined at equilibrium, since the films 
exist in a tension free state.  For bilayers it is the lateral compressibility that is the useful 
parameter when discussing such properties as protein insertion or conformational changes.  In 
monolayers, lateral compressibility can be directly measured from the slope of the pressure-
area isotherm.  This illustrates the utility of comparative studies done with both monolayers and 
bilayers.  While monolayers often provide a more direct measure of quantities such as surface 
pressure and compressibility, bilayers provide a more faithful representation of biological 
membranes.  This necessitates a need for measurable parameters which establish 
corresponding states between monolayers and bilayers.   
While surface pressure in monolayers is a thermodynamically precise quantity, for 
bilayers a more relaxed quantity, termed the equivalent surface pressure, is often discussed.  
The equivalent surface pressure is the collective interactions that balance the cohesive bilayer 
pressure that arises from the hydrophobic interactions between the lipid acyl chains and water.3  
Quantifying an equivalent surface pressure in bilayers is obviously important for studies 
comparing properties of monolayers and bilayers and for establishing conditions under which 
monolayers can be used as bilayer mimics.   
While direct measures of surface pressure in bilayers is not possible, the monolayer-
bilayer equivalence pressure can be established through indirect studies comparing their 
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properties.  For example, the partitioning of dibucaine, a local anesthetic, with monolayers of 1-
palmitoyl-2-oleoyl phosphatidylcholine (POPC) at a surface pressure of 30.7-32.5 mN/m closely 
matched that in bilayers, suggesting similar surface pressures.7  A similar study found that the 
partitioning of myristic acid into phosphatidylcholine bilayers closely matched that of 
monolayers compressed to a surface pressure of 35 mN/m.1  Finally, the partitioning of the small 
22 residue peptide, phosphotransferase glucitol permease, into POPC vesicles was found to be 
similar to POPC monolayers compressed to a surface pressure of 32 mN/m.5  Assuming that the 
insertion of species is similar in monolayers and bilayers, these partitioning studies suggest that 
bilayers have an equivalent surface pressure of ~30-35 mN/m.   
Equilibrium spreading experiments have also been used to estimate the bilayer 
equivalence pressure.  Vesicles in a subphase are allowed to form bilayers across an opening 
separating two solutions and form a monolayer at the air/subphase interface.  When these films 
reach equilibrium, measurement of the surface pressure at the air/subphase interface yields 
insight into the equivalent surface pressure of the suspended bilayer.  Using vesicles from the 
Torpedo electroplax, an equivalence bilayer pressure was estimated to be ~34 mN/m using this 
technique.6   
Previous studies in our group have shown out-of-focus single-molecule fluorescence 
measurements can be used to quantify the orientation of single dye molecules doped into lipid 
monolayers of DPPC.11  Several groups have shown that polarized total internal reflection 
fluorescence microscopy (PTIRF-M) can be used to quantify the three-dimensional orientation of 
dye molecules in samples when spherical aberrations are introduced into the optics train 
through defocusing.12-16  Using this approach, it was shown that the orientation of fluorescent 
lipid analogs doped into LB monolayers of DPPC could be used to track membrane order.  Here 
these measurements are extended to fully explore the single-molecule orientation of BODIPY-PC 
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doped in DPPC monolayers as a function of surface pressure.  Results from these measurements 
are used to find the equivalent surface pressure in DPPC bilayers formed through vesicle fusion 
onto a substrate.  Single-molecule orientation measurements suggest that supported DPPC 
bilayers formed from both giant unilamellar vesicles (GUVs) and small unilamellar vesicles 
(SUVs) exhibit equivalent surface pressures of ∼23 mN/m.  This value is somewhat smaller than 
the currently accepted value of ∼30 to 35 mN/m.1-7   
Having established a corresponding surface pressure between monolayers and bilayers 
of DPPC, single-molecule orientation measurements are used to compare the effects of 
biologically relevant sterols added to the lipid films.  Cholesterol is an essential component of 
biological membranes that contributes up to 40-50 mol % of the plasma membrane in 
eukaryotic cells and leads to a well known condensing effect when added to membranes 
containing saturated lipids such as DPPC.17-19  In general, this condensation of the lipids leads to 
an increase in lateral packing and ordering of the hydrocarbon chains, a reduction in the area 
per molecule, decreased membrane permeability, and an increase in membrane mechanical 
strength.17-21   
Ergosterol is a plant sterol similar in structure to cholesterol which differs by an extra 
double bond in the acyl chain.  The effects of ergosterol on membrane properties is less clear 
with some studies suggesting it has a greater condensing effect than cholesterol while others 
suggest the opposite.8,22,23  Finally lanosterol, a biological precursor to cholesterol, is known to 
induce little condensing effects when added to model membranes.8,22,23  These sterols therefore 
demonstrate a range of effects on membrane properties that are explored at the single-
molecule level using defocused PTIRF-M measurements.   
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5.2 Materials and Methods 
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) (Avanti Polar Lipids, Alabaster, AL), 
cholesterol (>99%), ergosterol (≥98), and lanosterol (≥97%) (Sigma Aldrich, St Louis, MO) were 
obtained and used without further purification.  The fluorescent lipid analog 2-(5-butyl-4,4-
difluoro-4-bora-3a,4a-diaza-s-indacene-3-nonanoyl)-1-hexadecanoyl-sn-glycero-3-
phosphocholine (β-C4-BODIPY 500/510 C9 HPC) (BODIPY-PC) (Invitrogen Corporation, Carlsbad, 
CA, B3794) was doped into lipid films at a concentration of ~10-8 mol %. 
5.2.1 Langmuir-Blodgett Preparation of Lipid Monolayers 
For the preparation of monolayers, DPPC was dissolved in chloroform (1mg/ml stock 
solutions) and the desired amount of sterol was added.  The solutions were doped with ~10-8 
mol % BODIPY-PC reporter dye, and dispersed onto a subphase of ultra-pure water (18 MΩ) in a 
Langmuir-Blodgett trough (Type 611, Nima Technology, Coventry, England).  Once dispersed on 
the subphase, the chloroform was allowed to evaporate for 15 minutes.  DPPC monolayers were 
compressed at a speed of 100 cm2/min to approximately 45 mN/m and then expanded at a 
speed of 80 cm2/min.  The compression/expansion cycles were repeated twice to anneal the 
monolayer.  The monolayer film was then compressed to the target pressure, held for 
approximately 15-20 minutes, and then transferred in a headgroup down geometry onto a 
Piranha cleaned glass substrate at a dipping speed of 25 mm/min.  All monolayers were 
prepared at a temperature of ∼21oC.   
5.2.2 DPPC Bilayer Formation Through Vesicle Fusion 
For the preparation of supported DPPC bilayers, the appropriate mol% of each sterol 
was added into a 5mg/mL chloroform solution of DPPC.  After doping each solution with ~10-8 
mol % BODIPY-PC reporter dye, 380 μL of DPPC / sterol solution was added to a separate vial, 
evaporated to dryness with nitrogen, and placed under vacuum for ~1hr to remove residual 
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solvent.  The DPPC/sterol mixtures were reconstituted in a buffer solution containing 20 mM 
HEPES, 100 mM NaCl, and 0.02 wt % NaN3 adjusted to neutral pH.  The vials were capped and 
incubated at ~60 oC for 1hr to hydrate the phospholipids.  The suspensions were vortexed and 
sonicated to clarity, yielding small unilamellar vesicles (SUVs).  The SUV suspensions were 
incubated in PDMS wells on Piranha cleaned glass for 30 min at 60 oC.  The wells were 
thoroughly washed with nanopure water to remove unruptured vesicles, and the excess water 
was removed immediately before imaging. 
Supported lipid bilayers were also formed using giant unilamellar vesicles (GUVs) 
prepared by electroformation.  Briefly, 50 μL of a 5 mg/mL chloroform solution of DPPC/sterol 
with ~10-8 mol% BODIPY-PC reporter dye was deposited on two microscope slides coated with 
indium tin oxide (ITO).  The solution was dried onto the slides under vacuum for ~1 hr.  The 
coated slides were rehydrated with ~1 mL of 18 MΩ water and sandwiched together with a 1.5 
mm thick PDMS gasket.  The slide assembly was placed on a temperature-controlled stage set to 
50 °C and the lipids were allowed to hydrate for ~20 minutes.  Following hydration, a function 
generator was used to apply a 10 Hz, 1 V sine wave across the ITO coated slides for ~3hr to 
produce giant unilamellar vesicles.  The GUVs were detached from the surface by reducing the 
frequency to 1Hz for ~30 min, after which the suspension was isolated. 
5.2.3 Imaging Approach 
All films were imaged using a total internal reflection fluorescence microscope (TIRF-M) 
(Olympus IX71, Center Valley, PA) equipped with a 100x objective (1.45 NA achromat).  The 514 
nm line from an argon ion laser (Coherent Innova 70 Spectrum, Santa Clara, CA) was directed 
through half-wave and quarter-wave plates (Newport, Irvine, CA) to generate p-polarized 
excitation.  Excitation was directed through the objective and fluorescence collected in an 
epifluorescence geometry with the optics defocused ~500 nm.  The fluorescence was filtered 
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with a combination of a dichroic mirror and long pass filters (Chroma, Rockingham, VT) and 
imaged onto a CCD camera (Cascade 650, Roper Scientific, Tucson, AR).  Image collection was 
controlled with Slidebook software (Version 4.2, Intelligent Imaging Innovations, Denver, CO) 
and analyzed using MatLab software (Natick, MA).   
5.3 Results and Discussion 
Initial work in our group has shown that single-molecule fluorescence measurements 
using PTIRF-M can reveal insight into membrane structure at the molecular level.11  Here we 
expand those initial studies to characterize the equivalent surface pressure in bilayers and 
compare both monolayers and bilayers doped with the biologically important sterols 
cholesterol, ergosterol, and lanosterol.  Figure 5.3.1 shows the structures of DPPC and the 
sterols studied along with the fluorescent lipid analogue, BODIPY-PC that was doped into the 
membranes to act as the reporter probe.   
 
Figure 5.1:  Structures of DPPC and the sterols studied in both monolayers and bilayers.  Also 
shown is the fluorescent lipid analog BODIPY-PC along with a schematic representation of its 
insertion into a monolayer membrane. 
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Other studies have shown that unique single-molecule emission patterns are observed 
in slightly defocused PTIRF-M images, which reflect the orientation of the dye in the sample.12-
16,24  Analysis of the emission patterns, therefore, enables the three-dimensional orientation of 
each dye molecule doped into the lipid film to be characterized.  BODIPY-PC was chosen as the 
fluorescent reporter dye due to its placement of the fluorophore in the tailgroup, which has 
been shown to be sensitive to membrane order.11  The absorption and emission dipoles of 
BODIPY-PC lie along the long axis of the chromophore with ~13˚ between the two.25 
5.3.1 Surface Pressure Studies 
Figure 5.2 shows representative single-molecule emission images of ~10-8 mol% 
BODIPY-PC doped into DPPC monolayers, which were transferred onto glass substrates at 
surface pressures of 3 mN/m, 25mN/m, and 40 mN/m using the Langmuir-Blodgett (LB) 
technique.  As the surface pressure of the LB monolayers is increased, an evolution towards 
donut-shaped emission features is observed which arise from emission dipoles oriented normal 
to the membrane plane.  As shown by others, these emission patterns can be modeled to 
quantitatively extract the three-dimensional orientation of the emission dipoles in the sample.12-
16  Using this approach, each emission feature is analyzed to extract the tilt angle (Φ) away from 
the membrane normal.  Figure 5.2 shows representative tilt angle histograms for monolayers 
prepared at five different surface pressures along with the number of molecules analyzed at 
each pressure.   
At a surface pressure of 3 mN/m, the single-molecule tilt histogram reveals most of the 
dye probes are oriented in the plane of the film (≥81˚), reflecting the disorder in the DPPC 
monolayer at low surface pressures.  This is seen in the corresponding emission image which 
contains mostly single-molecule features consisting of bright spots surrounded by wings that are 
characteristic of molecules oriented with large tilt angles.  The tilt angle histogram, therefore, 
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reveals a large population of emission dipoles oriented in the plane of the film with a smaller 
population spread through the remaining angles.  The average tilt angle calculated from the 
histogram is 67.4 ± 5˚ (N = 711) at a surface pressure of 3 mN/m.  
 
Figure 5.2:  Representative single molecule fluorescence images of BODIPY-PC reporter 
molecules doped into DPPC monolayers at left, with their corresponding orientation 
histograms shown at right. 
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At the other surface pressure extreme, the single-molecule emission image for DPPC 
transferred at 40 mN/m reveals a large population of donut-like features reflecting emission 
dipoles that are oriented normal to the membrane surface.  The corresponding tilt angle 
histogram shown in Fig. 5.2 reveals that most of the dye population have tilt angles ≤10˚ at this 
elevated surface pressure.  This reflects the increased membrane order in the lipid monolayer at 
40 mN/m, which reduces the average tilt angle to 22.4 ± 5˚ (N = 764).   
At intermediate surface pressures, Fig. 5.2 reveals bimodal tilt distributions with the 
majority of molecules adopting orientations either normal or parallel to the membrane plane, 
with fewer adopting intermediate tilts.  The bimodal distribution in tilt angles reflects BODIPY-
PC partitioning into the lipid phases in the DPPC monolayer.  At intermediate surface pressures, 
DPPC monolayers partition into domains of less ordered liquid-expanded (LE) phase and more 
ordered liquid-condensed (LC) phase leading to the observed bimodal tilt distribution.   
As shown in Fig. 5.2 there is a steady rise in the population of molecules oriented 
normal to the DPPC monolayer as the surface pressure of the film is increased.  A plot of the 
population of molecules oriented normal to the surface (Φ ≤ 10˚) as a function of surface 
pressure is shown in Fig. 3.  DPPC monolayers were transferred onto glass substrates at eight 
different surface pressures between 3 mN/m and 45 mN/m with the results plotted in Fig. 5.3.  
The linear dependence with surface pressure provides a convenient marker of membrane order 
and a useful calibration for characterizing the surface pressure in bilayers.  Also shown in Fig. 5.3 
is the percent LC area in the monolayers as a function of surface pressure. 
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The tilt angle histogram measured for supported bilayers in Fig. 5.4 can now be used to 
estimate the equivalence surface pressure of the bilayer using the data plotted for monolayers 
in Fig. 5.3.  From the histogram in Fig. 5.4, the percentage of emission dipoles oriented normal 
to the membrane plane (Φ ≤ 10˚) in supported bilayers of DPPC is 41%.  This point is shown in 
Fig. 5.3 and translates into an equivalent surface pressure of ∼23 mN/m.  Single-molecule 
measurements on supported bilayers formed from both small unilamellar vesicles (SUV’s) and 
giant unilamellar vesicles (GUV’s) resulted in statistically identical results.  This equivalent 
surface pressure is somewhat smaller than the values obtained from other experiments (∼30-35 
mN/m).1-7 
5.3.3 Additive Effects on Membrane Structure 
Having established the equivalent surface pressure for supported DPPC bilayers, the 
influence of sterol additives were compared in both LB monolayers transferred at 23 mN/m and 
DPPC bilayers.  Cholesterol is widely distributed in biological membranes and exerts a well-
known condensing effect.17-20,26,27  The profound influence of cholesterol on membrane 
properties can be traced to its structure, which is shown in Fig. 5.1.  Cholesterol consists of a 
fused ring structure that is responsible for its rigid, planar geometry.  There is a single hydroxyl 
group located at the C3 position and an iso-octyl acyl chain extending from the opposite side of 
the ring at position C17.  Two methyl groups extend from the same side of the ring structure as 
the acyl chain, forming a β-configuration.  When cholesterol inserts into lipid monolayers and 
bilayers, it orients with its polar hydroxyl group lying towards the hydrophilic phospholipid 
headgroups and the hydrophobic ring structure aligned along the lipid acyl chains.  The cohesive 
interactions between cholesterol and the lipid acyl chains are strongly linked with the degree of 
lipid saturation, making these interactions particularly important for lipids such as DPPC. 
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the ordered abundance (Φ ≤10˚) increases from 42% to 59% in monolayers and from 41% to 
52% in bilayers.  The single-molecule tilt histograms summarized in Fig. 5.5 reveal a steady 
increase in the ordering of the acyl chains with increasing cholesterol content for both 
monolayers and bilayers.  As cholesterol is increased, a steady rise in the number of BODIPY-PC 
molecules oriented normal to the plane (Φ ≤ 10˚) is observed with an associated drop in the 
population oriented in the membrane plane (Φ ≥ 81˚). 
Ergosterol and lanosterol provide useful structural analogs of cholesterol that can help 
clarify the unique role of cholesterol in modifying membrane properties.  Ergosterol is generally 
found in the membranes of plants, while lanosterol predates cholesterol in the evolutionary 
pathway.  As shown in Fig. 5.1, ergosterol is very similar to cholesterol and only differs slightly 
with a carbon-carbon double bond in the second steroid ring, an unsaturated side chain, and 
methylation at position C24.  Both cholesterol and ergosterol lead to condensing effects in 
membranes, although there is some disagreement regarding which has a larger effect.8,22,23  
Lanosterol, on the other hand, has three extra methyl groups on the α-surface of the ring 
system that are believed to increase the steric costs associated with membrane insertion (Fig. 
5.1).  Although lanosterol still has a condensing effect on membranes, studies agree that the 
effect is much smaller than that of either cholesterol or ergosterol.8,22,23 
Figure 5.6 summarizes the results from defocused single-molecule PTIRF-M studies on 
monolayers and bilayers incorporating cholesterol, ergosterol, and lanosterol as a function of 
sterol concentration.  Sterol concentrations of 0 mol%, 5 mol%, 10 mol%, and 33 mol% sterol 
are compared.  Once again, LB monolayers were transferred at a surface pressure of ~23 mN/m 
to match the bilayer equivalent surface pressure determined earlier.  The results are 
summarized in Fig. 5.6 which plots the percentage of BODIPY-PC molecules oriented normal to 
the membrane plane (Φ ≤ 10˚) as a function of sterol concentration.  The plot in Fig. 5.6-A shows 
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observed at low ergosterol concentrations and only becomes significant in the single-molecule 
results at higher ergosterol concentration.  For lanosterol, single-molecule orientation 
measurements reveal little influence on membrane ordering.  Figure 5.6-C shows that the 
percentage of single-molecules oriented normal to the plane remains essentially constant for 
both monolayers and bilayers throughout the concentrations studied.    
The bimodal distribution of single-molecule orientations observed in DPPC bilayers 
suggest coexisting lipid phases are present in both pure DPPC bilayers and those in which 
cholesterol has been added.  Bulk fluorescence measurements on similar films find no evidence 
for coexisting domains on the sub-micron length scale.28  However, both energy transfer 
measurements and some NMR studies have found evidence for coexisting domains in these 
systems.9,29-31  These differences are often ascribed to the different length/time scales that are 
probed by the different techniques.  The results shown here suggest single-molecule orientation 
measurements can provide a unique view of model lipid film properties that compliments other 
well established approaches.   
The influence of cholesterol on high melting temperature lipids such as DPPC has been 
widely studied, yet a clear picture of its effects has yet to emerge.  Different phase diagrams 
have been constructed based on results using different techniques, but most agree that these 
mixed bilayers can exist in the gel phase (So), liquid-crystalline (Lα), and liquid-ordered (Lo) 
states.  The latter is a cholesterol induced state whose name summarizes the combination of 
structural order with liquid-like dynamics in this state.  The well-known condensing effects of 
cholesterol lead to extended acyl chains in this state, while translational diffusion and rotational 
motion remain liquid-like.17-21 
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There is a striking similarity in the trends that are observed from our room temperature 
single-molecule studies and previous studies done above the transition temperature.  Order 
parameters calculated using the average tilt angle from the single-molecule histograms show a 
sharp rise in S at low cholesterol concentration that levels off at higher concentrations.  As 
shown in Fig. 5.7, this agrees closely with S values calculated from X-ray studies done at 45 oC.10  
Similar trends are also observed in the NMR and fluorescence studies carried out at 45 oC.   
Also plotted in Fig. 5.7 are the results from NMR and fluorescence anisotropy studies 
done at room temperature that reveal high initial S values that decrease with cholesterol 
content.8,9  These changes do not track the changes we find in the single-molecule 
measurements which can be understood by recognizing that different techniques measure 
different aspects of membrane order.  For example, S values derived from the NMR experiments 
provide a measure of the orientational freedom around the acyl chain axis.  These 
measurements, therefore, provide insight into membrane packing.  At room temperature, below 
the melting temperature for DPPC, NMR measurements of pure DPPC films yield high values for 
the order parameter.  This results from the small degree of rotational freedom around the acyl 
chains and the high degree of lateral packing in the So phase.  Upon the addition of cholesterol, 
however, the S values decrease due to the disruption of the gel state packing and increase in 
acyl chain freedom.  Additional cholesterol further disrupts the lateral packing of the film and 
leads to the formation of the Lo phase, which has a greater degree of rotational freedom and 
thus a smaller S as compared to the gel phase.   
Above the melting temperature, NMR studies of pure DPPC films in the fluid state yield 
S values that are small.  The low S values arise from the increased freedom around the 
disordered acyl chains in this state.  The addition of cholesterol, which has a condensing effect 
on DPPC, therefore, increases the order parameter as the Lo phase is formed.  This transition is 
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accompanied by a gel-like lateral packing with diffusional characteristics similar to the fluid 
phase. 
For the single-molecule measurements summarized here at room temperature, the acyl 
chains in pure DPPC films have a high lateral packing and large tilt angles with respect to the 
membrane normal which leads to the low calculated S values.  The addition of cholesterol, 
which induces Lo phase formation, increases acyl chain order which is reflected in the PTIRF-M 
images as an increase in donut-like single-molecule emission features.  This results in the large 
increase in S values calculated from the single-molecule measurements as cholesterol is 
increased.  Since the NMR measurements track the lateral packing and rotational freedom of 
the acyl chains and the single-molecule measurements quantify the orientation of the acyl 
chains with respect to the membrane normal, the differences observed at room temperature in 
Fig. 5.7 are expected.  At elevated temperature, however, the onset of the Lo phase increases 
lateral packing and decreases acyl chain tilt with respect to the membrane normal.  This explains 
why the room temperature single-molecule measurements closely agree with previous studies 
done at 45 oC.  Therefore, despite the differences in temperature between these studies, Fig. 5.7 
reveals very good agreement between the single-molecule results and bulk measures of 
cholesterol added to DPPC membranes.    
While the average single-molecule orientations leads to agreement with previous 
studies characterizing S in model mixed membranes of DPPC and cholesterol, the bimodal 
distribution observed illustrates the detailed information available from measuring the entire 
orientation distribution.  Using single-molecules as probes of lipid environments can 
complement other more established techniques and provides a new tool for understanding 
these complicated systems at the molecular level.   
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5.4 Conclusions 
Single-molecule fluorescence measurements taken using out-of-focus PTIRF-M are used 
to characterize the three-dimensional orientation of single BODIPY-PC dye molecules doped into 
model films of DPPC.  For LB monolayers of DPPC, characterization of single-molecule 
orientation histograms as a function of surface pressure reveals an evolution in membrane 
order.  At all surface pressures studied, a bimodal orientation histogram is observed which 
reflects the coexisting LE and LC phases present in the monolayer.  There is a linear dependence 
in the number of BODIPY-PC molecules with transition dipoles oriented normal to the surface 
with surface pressure which is used to find the equivalent surface pressure in supported 
bilayers.  Comparison of the single-molecule orientation histogram from DPPC bilayers with the 
results from the LB monolayers suggests an equivalent surface pressure of ∼23 mN/m for 
bilayers.  This is somewhat lower than the currently accepted value of ∼30-35 mN/m.1-4,6,7  
With the equivalent surface pressure for bilayers established, single-molecule studies 
comparing the effects of cholesterol, ergosterol, and lanosterol on membrane properties are 
compared between DPPC bilayers and LB monolayers transferred at ~23 mN/m.  Single-
molecule orientation as a function of sterol content tracked closely between monolayers and 
bilayers.  Cholesterol had the largest effect on membrane order, increasing the number of 
BODIPY-PC molecules oriented normal to the surface even at low cholesterol content.  
Lanosterol had essentially no effect on the single-molecule orientations while ergosterol did 
affect orientations, but to a lesser extent than cholesterol.  Using the average orientation from 
the histograms as a function of cholesterol content, the order parameter S was calculated and 
compared with previous NMR and X-ray studies.9,10  Close agreement is observed between the 
room temperature single-molecule results and previous bulk measures of membrane order 
done at higher temperatures. 
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 These studies show that single-molecule fluorescence orientation measurements can be 
used to track the molecular level structure in model membrane systems.  These studies, 
however, were all performed on dry samples that were exposed to the atmosphere.  In order to 
further explore the ability of this single-molecule method to examine model systems 
approaching aqueous conditions, Chapter 6 is centered on the roles that hydration and the 
underlying substrate play in affecting the structure and dynamics of model membrane systems. 
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Chapter 6:  Hydration Effects on Membrane Structure Probed by Single Molecule Orientations 
 Our single-molecule studies to this point have been employed on static systems in a dry 
atmosphere.  As our future goals encompass single-molecule studies used to determine antibody 
orientations in a dynamic, fluid environment, it is important to explore the time-resolved capabilities of 
this approach and its feasibility in conditions approaching fluid environments.  The following study 
examines the structural and dynamic effects that hydration has on model membrane films at the 
molecular level. 
6.1 Introduction 
Supported lipid monolayer and bilayer membranes have provided useful test systems to study 
lipid phase behavior, probe the role of membrane constituents such as cholesterol, and for the 
development of biosensing platforms.1-11  Numerous techniques have been developed to create and 
deposit lipid films onto substrates where they are amenable for study with high resolution techniques.  
These studies have been largely aimed at understanding the role of lipids in biological membranes, the 
structures lipids form, and how different constituents interact with or insert into membrane structures.2-
3, 6-8, 12-19  
For supported lipid membranes, extensive studies have been devoted to understanding and 
characterizing the influence that the substrate can have on membrane properties.20-26  These studies can 
take many forms but usually revolve around understanding the role that the substrate plays in 
influencing membrane structure, fluidity, and in modifying the activity of membrane incorporated 
species.20-26  These studies are important from both fundamental and practical viewpoints.  For applied 
applications of supported model membranes in devices such as sensor platforms, characterizing the 
underlying effects of the substrate on membrane stability and responsiveness is of obvious importance.  
For fundamental studies where supported membranes are used to mimic natural membranes, the 
influence of substrate and environmental condition on membrane properties must be understood to put 
  97 
 
the results in the proper context.  Factors such as ionic strength, pH, temperature, and substrate identity 
can all have a profound influence on membrane orientation, integrity, and fluidity.21-22, 24, 27-28 
Previous studies have helped define the significant role that relative humidity (RH) can play in 
influencing the structure of supported lipid films.20, 29-34  On the macroscopic scale, RH levels have been 
found to influence the lateral diffusion of supported lipid films.  For example, fluorescence recovery 
after photobleaching (FRAP) measurements on multilayer films of egg phosphatidylcholine found an 8-
fold increase in the diffusion coefficients of NBD-PE with increasing RH.33  In general, increasing lateral 
diffusion with RH has also been observed for monolayer lipid films, with the extent strongly tied to the 
nature of the underlying support.  Monolayers of DMPC and DphyPC deposited onto polysaccharide 
cushions exhibit greater lateral diffusion than, for example, monolayers transferred directly onto glass.20  
The emerging picture from these and other studies suggests that lateral diffusion is an activated process 
in which the activation energy is linked to the extent of lipid headgroup hydration level.  Increasing the 
hydrated radius of the headgroup decreases the electrostatic interactions with the substrate, thus 
lowering the barrier height for lateral diffusion.   
At the molecular level, spectroscopic measurements of lipid membranes have provided insight 
into the structural changes that accompany changes in the RH.27, 35-40  Polarized IR studies of acyl chain 
tilt angle found decreasing order parameters with increasing hydration, suggesting a reorientation of the 
acyl chain towards the supporting surface.27, 35-36  Similar studies on bilayer membranes using a number 
of lipid compositions generally found reorientation of the acyl chains with increasing RH.  Raman 
measurements on multilamellar DMPC membranes found evidence for both small and dramatic changes 
in acyl chain order with increasing RH.39-40  The small shifts in acyl chain order were assigned to 
reorientations of the lipids in the membrane with RH while the larger shifts were attributed to phase 
changes in the membrane.  Differential scanning calorimetry studies have also found evidence for phase 
changes in supported lipid membranes with RH.41-43  For example, the gel phase transition temperature 
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for DPPC has been reported to increase from ~ 41 °C in the completely hydrated state to ~102 °C in the 
fully dehydrated state.42 
X-ray studies on model membranes have also found evidence for increasing acyl tilt angle with 
increasing RH.28, 44-50  Several studies have shown that the tilt angle in multilayer DPPC films increases 
from a lower limit of 17-22° in the dehydrated state to an upper limit of ~32° in a fully hydrated 
membrane.44-45, 51  Similar trends with smaller magnitudes were observed for DMPC multilayers in which 
tilt angles increased from 26° to 30° as the membrane was hydrated.28  At elevated RH, water uptake by 
the lipid headgroups correlates with increasing tilt angles again suggesting that headgroup hydration can 
effect overall membrane structure.    
Clearly, supported membrane systems are appreciably influenced by ambient RH and further 
studies are warranted to characterize its influence on membrane structure and fluidity.  The recent 
emergence of single molecule fluorescence measurements offers a new approach for probing 
membrane properties at the molecular level.  Single molecule fluorescence measurements can 
characterize the three-dimensional orientation of individual fluorescent markers doped into lipid films at 
trace levels.52-61  Orientational changes of fluorescent lipid probes have been shown to be sensitive to 
membrane organization and have been used to characterize changes in membrane structure with 
surface pressure and membrane composition.15, 62-65  The method is minimally perturbative since only 
trace amounts of a fluorescent lipid analog are needed and, since measurements are made on individual 
molecules in the sample, it does not suffer from the loss of information due to ensemble averaging.  This 
is especially useful for model membranes which often exhibit structural heterogeneity.1, 3-5, 7, 10, 13-14, 18-19, 
66-67 
Here we use single molecule orientation measurements to characterize the response of LB films 
of DPPC to changes in relative humidity.  Single molecule orientation measurements reveal that DPPC 
films transferred at both low (23 mN/m) and high (40 mN/m) surface pressures reveal changes in single 
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molecule orientations with RH.  Comparison with films fabricated using the vesicle fusion method shows 
that structural changes as a function of RH more closely track changes seen in LB films transferred at 23 
mN/m.  Finally, single molecule orientation measurements with time reveal changes in the orientational 
freedom around fluorescent lipid analogs as a function of RH.  These changes in orientational freedom 
are not associated with long range translational changes observed in bulk measures of diffusion, 
illustrating the complementary nature of single molecule measurements with ensemble averaged 
techniques. 
6.2 Materials and Methods 
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) (Avanti Polar Lipids, Alabaster, AL) was 
obtained and used without further purification.  The fluorescent analog, 2-(5-butyl-4,4-difluoro-4-bora-
3a,4a-diaza-s-indacene-3-nonanoyl)-1-hexadecanoyl-sn-glycero-3-phosphocholine (BODIPY-PC, B3794) 
(Invitrogen Corporation, Carlsbad, CA) was doped into the lipid films at 10-8 mol% concentration. 
 6.2.1 Bilayer Fabrication Through Vesicle Fusion 
The preparation of supported lipid bilayers using vesicle fusion was carried out as described 
elsewhere.15  Briefly, a 5mg/mL solution of DPPC in chloroform was doped with 10-8 mol% of BODIPY-PC.  
380μL of this solution was placed in a separate vial and evaporated to dryness with nitrogen, after which 
the film was placed under vacuum for ~1hr to remove residual solvent.  A 20mM HEPES, 100mM NaCl, 
0.02 wt% NaN3 buffer solution adjusted to neutral pH was used to rehydrate the lipid films at 60°C for 
1hr.  The solution was then sonicated to clarity to yield small, unilamellar vesicles (SUVs).  The SUV 
suspension was incubated in PDMS wells on piranha-cleaned glass slides for 30 min at 60°C and allowed 
to cool to room temperature.  In order to form bilayers labeled in the distal leaflet only, a solution of 
BODIPY-PC sonicated in buffer was incubated over bilayers formed without dye for 10 min.  The PDMS 
wells were thoroughly rinsed, the excess water was removed, and the resulting bilayer was exposed to 
the desired relative humidity for imaging. 
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 6.2.2 Bilayer Fabrication by Langmuir-Blodgett/Langmuir-Schäfer Transfer 
Supported bilayers were also fabricated using the Langmuir-Blodgett/Langmuir-Schäfer (LB/LS) 
technique.  Unlabeled DPPC was dissolved in chloroform and spread onto a 18MΩ water subphase in a 
Langmuir-Blodgett trough (Nima Type 611, Coventry, England).  Two compression-expansion cycles were 
carried out before compressing the film to the desired surface pressure.  Once compressed to the 
desired surface pressure the monolayer was allowed to equilibrate for 15 min before depositing onto a 
piranha-cleaned glass substrate in a headgroup down geometry.  The monolayer on the subphase was 
then replaced with DPPC doped with 10-8 mol% BODIPY-PC.  Following the same compression protocol, a 
second monolayer was deposited on the first using the Langmuir-Schäfer technique.  The resulting 
bilayer was allowed to equilibrate for 10 minutes at the desired RH before imaging. 
 6.2.3 Imaging Approach 
The bilayer films were imaged using a total internal reflection microscope (TIRF-M) (Olympus 
IX71, Center Valley, PA) equipped with a 100x objective (1.45 NA Achromat, Olympus).  The 514 nm line 
from an argon ion laser (Coherent Innova 90, Santa Clara, CA) was directed through half-wave and 
quarter-wave plates (Newport, Irvine, CA) to control the polarization before being coupled into the 
microscope.  P-polarized excitation was used and the fluorescence collected, filtered, and imaged on a 
cooled CCD camera (Cascade 650, Roper Scientific, Tuscon, AZ).  To measure single molecule 
orientations, the optics were defocused ~500nm.  Image collection was controlled by Slidebook 
software (Intelligent Imaging Innovations, Denver, CO) and analyzed using MATLAB (Natick, MA).   
6.3 Results and Discussion 
It has been previously shown that defocused single molecule emission measurements obtained 
with PTIRF-M can be used to track changes in lipid film structure at the molecular level.15, 62  Using the 
reporter dye BODIPY-PC doped into DPPC films in trace amounts, it was shown that orientation changes 
in the membrane probe tracked changes in film surface pressure and the presence of film additives such 
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as cholesterol.  These results showed that at both high surface pressures and high cholesterol content, 
single molecule emission patterns from BODIPY-PC doped into DPPC reflected a more ordered 
environment consistent with the condensing effects expected under these conditions.  Here we expand 
these studies to probe the role that relative humidity (RH) has on supported model DPPC bilayers 
formed through vesicle fusion and the Langmuir-Blodgett/Langmuir-Schäfer (LB/LS) techniques. 
 
6.3.1 Static Effects of Hydration on Membrane Structure 
The top panel in Fig. 6.1 shows a typical single molecule emission image of a DPPC bilayer 
measured using defocused PTIRF-M.  Each bright feature in the fluorescence image represents the 
emission from a single BODIPY-PC fluorescent lipid analog doped into the bilayer.  The supported bilayer 
was formed using the LB/LS method, with each leaflet transferred at a surface pressure of 23 mN/m.  
This surface pressure has been shown previously to approximate the “equivalent surface pressure” for 
bilayers formed using the vesicle fusion method.15, 68 
As others have shown, the distinct shapes observed in defocused single molecule P-TIRF images 
such as that in Fig. 6.1 reflect the orientation of each dye molecule.52-55, 58-61, 68-70  Donut-like shapes arise 
from emission dipoles oriented normal to the membrane plane while more complicated patterns with 
wings are observed at larger tilt angles.  These patterns can be analyzed to extract both the polar (Φ) 
and azimuthal (θ) angles of the emission dipole as shown schematically in the middle panel of Fig. 6.1. 52-
55, 58-61, 68-70  
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Figure 6.1:  Top panel:  Representative single molecule image of a DPPC bilayer transferred using the 
Langmuir-Blodgett/Langmuir-Schäfer technique at 23 mN/m and 13% relative humidity.  Middle panel:  
Schematic diagram illustrating the three-dimensional orientation of emission dipoles collected from the 
image in the top panel.  Bottom panel:  Orientation histogram representing the polar angle distribution 
of 547 single molecule orientations collected at the stated conditions. 
Analysis of 547 single molecule dipole orientations is used to develop the tilt angle (Φ) 
histogram shown in the bottom panel of Fig. 6.1.  The polar or tilt angle of the emission dipoles away 
from the membrane normal is most sensitive to changes in membrane structure and will be used here to 
follow changes associated with increasing RH.15, 62  The tilt angle histogram reveals a bimodal 
distribution with most of the population found in either in upright orientations (≤10o) or lying nearly 
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parallel with the membrane surface (≥81o).  The population histogram in Fig. 6.1 reveals that 47% and 
30% of the single molecule population are oriented normal (≤10o) and parallel (≥81o) with the 
membrane surface, respectively.  The bimodal distribution likely reflects the well-known propensity of 
BODIPY-PC to insert into membranes with the chromophore oriented either along the acyl chains or 
bent back towards the headgroup.71-76  It may also reflect the coexisting lipid phases present in these 
membranes.  Regardless, previous studies have shown that the orientation distribution is sensitive to 
membrane surface pressure and the incorporation of membrane additives such as cholesterol, making 
single molecule orientations a sensitive marker of membrane structure.15, 62  
The single molecule tilt angle distribution can be used to compare the effects of increasing RH as 
shown in Fig. 6.2.  Figure 6.2 shows the results of single molecule measurements on LB/LS bilayers of 
DPPC doped with 10-8 mol% BODIPY-PC as a function of RH.  For these measurements only the outer 
leaflet was doped with the BODIPY-PC reporter dye and both leaflets were transferred at a surface 
pressure of 23 mN/m.  The left panels show representative single molecule emission measurements 
taken on supported LB/LS bilayers under conditions of 13%, 45%, 75%, and 95% relative humidity.  The 
panels on the right display the corresponding population histograms generated from the analysis of 
individual single molecule emission patterns from over 500 molecules at each condition.  At each RH, a 
minimum of three films were fabricated and measurements were taken in at least three different 
regions of interest to assure that the histograms reflect average properties of the films.   
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Figure 6.2 reveals a general trend in the single molecule orientations as a function of increasing 
RH that leads to a shift in population towards molecules oriented parallel to the membrane plane.  As 
RH increases, a decrease in population of molecules oriented normal to the surface is observed that is 
correlated with a rise in population with those molecules oriented parallel to the membrane.  At RH 
values of 13%, 45%, 75%, and 95% the population of molecules oriented normal to the membrane is 47, 
41, 23, and 15%, respectively.  This drop coincides with an increase in those oriented parallel to the 
surface of 30, 39, 51, and 55%, respectively.  Interestingly, the percentage of molecules oriented 
between these extremes remains fairly constant at 23, 20, 25, and 28%, respectively.   
As a comparison, Fig. 6.3 summarizes similar single molecule measurements taken on DPPC 
bilayers formed using the vesicle fusion method.  For these measurements, the fluorescent lipid analog 
BODIPY-PC was doped into the outer leaflet at 10-8 mol%.  These measurements, taken at the same RH 
values, reveal a similar dependence in the single molecule orientations with RH as bilayers formed using 
the LB/LS method (Fig. 6.2).  At low relative humidity, the single molecule population histograms reveal 
a bimodal distribution with slightly more molecules oriented normal to the membrane plane than those 
parallel to the plane.  At 13% RH, 42% are oriented with tilt angles between 0o and 10o while 35% are 
oriented with tilt angles between 81o and 90o.  As RH increases, the number of molecules oriented 
normal to the membrane decreases while those oriented in the plane increases until finally at 95% RH, 
15% are oriented normal and 64% are oriented parallel to the membrane plane.   
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A quantitative comparison between the RH dependence of bilayers formed using the LB/LS 
method (23 mN/m) and vesicle fusion can be seen in Fig. 6.4.  The graph in Fig. 6.4 compares the 
population of BODIPY-PC dye molecules oriented normal to the surface as a function of RH for bilayers 
formed using the two methods.  Also plotted in Fig. 6.4 are results for LB/LS bilayers transferred at a 
higher surface pressure of 40 mN/m.  As seen in Fig. 6.4, for all bilayers the population of normal 
oriented fluorophores generally decreases as a function of increasing RH.  The trends also reveal the 
close correspondence between bilayers formed from vesicle fusion and LB/LS bilayers transferred at 23 
mN/m.  The trend with RH for LB/LS bilayers transferred at 40 mN/m, however, clearly deviates from the 
others and is less sensitive to RH changes as expected for layers with higher lipid packing.  The close 
agreement in trends seen in Fig. 6.4 for LB/LS bilayers transferred at 23 mN/m and those fabricated 
from vesicle fusion further supports the assignment of an “equivalent surface pressure” for membranes 
formed through vesicle rupture of ~23 mN/m.15 
Figure 6.4:  Comparison of the ordered abundance of emission dipoles at each bilayer condition 
studied, comprised of all emission dipoles oriented ≤10° with the membrane normal, including 
membranes formed by vesicle fusion and the LB/LS technique at 23 and 40 mN/m.   
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For all films studied, analysis of the single molecule emission patterns reveal an increasing 
population of large tilt angles associated with elevated RH.  Previous studies have shown that headgroup 
hydration levels can strongly affect the lipid packing in supported lipid membranes which is consistent 
with the single molecule orientation trends.27-28, 35-36, 39-40, 44-49, 77  As the water content of the membrane 
is increased, there is an increase in the apparent tilt angle of the BODIPY-PC probe, suggesting a 
relaxation of the acyl chains in the membrane.   
At low RH, the dehydrated headgroups exhibit a reduced intermolecular distance, increasing 
pressure between each phospholipid.  This elevated pressure causes a greater packing effect in the film.  
As water activity is increased with elevated humidity, the hydrated radius of the hydrophilic headgroups 
increases and a swelling effect occurs, raising the intermolecular distance in the film.  This reduction in 
intermolecular pressure results in a relaxation of the acyl chains in the membrane which increases their 
tilt angle.  These trends agree with those seen in the single molecule orientations shown in Fig. 6.2.   
 For the supported membranes studied here, we find negligible changes in the bulk distribution 
of the dye marker BODIPY-PC with RH. At high dye loading (0.25 mol % BODIPY-PC), plots of the dark, 
condensed phase regions of the membranes as a function of RH reveal negligible changes for all 
supported films studied (data not shown). These measurements show that large scale bulk 
rearrangements of the dye marker are not taking place as the RH increases. These results also show that 
the changes observed in the single molecule measurements reflect local changes taking place in the 
membranes which are not associated with large scale changes in dye location. 
 6.3.2 Dynamic Effects of Hydration on Supported DPPC Membranes 
The single molecule measurements, however, do reveal that a small percentage of the individual 
dye molecules in the supported films do become laterally mobile as the RH increases.  Figure 6.5 plots 
the percent of BODIPY-PC molecules that visibly translate in the films as a function of RH.  As seen in the 
figure, the DPPC films studied exhibit an exponential increase in the population of BODIPY-PC molecules 
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that are mobile as RH increases.  Even at the highest RH studied here, however, the population of 
translationally active molecules remains less than 6%.  These trends are consistent with previous bulk 
measurements of diffusion made using fluorescence recovery after photobleaching (FRAP).20, 33 
Figure 6.5:  Comparison of the population of single molecule probes exhibiting lateral 
motion versus RH in bilayers formed by the LB/LS (23mN/m) and vesicle fusion methods. 
The population of single molecule probes laterally diffusing increases exponentially with 
relative humidity, reaching a maximum of ~6% for bilayers formed using vesicle fusion. 
 
Baumgart and Offenhäusser used FRAP measurements to characterize the diffusion of the 
fluorescent analog NBD-PC in LB monolayers of DMPC and DphyPC as a function of RH.20  Generally, they 
found an increase in diffusion with RH for monolayers transferred onto supported polymer cushions of 
chitosan or agarose and those deposited directly onto glass.  When monolayers were deposited directly 
onto glass, however, the diffusion was dramatically reduced.  Only at the highest RH levels studied were 
they able to resolve measurable diffusion signals above their detection threshold.  This is consistent with 
the relatively small population of mobile molecules observed here in the single molecule measurements 
at low RH levels.   
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As discussed previously, the influence of RH on lateral diffusion is an activated process, with the 
height of the activation barrier linked to headgroup hydration and the properties of the specific surface 
and lipid.  In general, at elevated RH levels where the headgroup is sufficiently hydrated, the lipid can 
overcome the electrostatic attraction with the surface and laterally diffuse.  Therefore, as shown in Fig. 
6.6, as RH increases the population of translationally active single molecules also increases. 
In addition to the lateral movement of single molecules in the lipid films, polar and azimuthal 
angle dynamics can also be resolved in a small population of dye molecules.  As an example, Fig. 6.7 
shows a series of single molecule emission images taken from the same 5 μm x 6 μm region of a 
supported DPPC bilayer formed from vesicle fusion.  Each sequential frame was collected using a 1 
second integration time with the RH of the film held constant at 13%.  Each frame shows 5 fluorescent 
features that arise from 5 BODIPY-PC molecules in the field of view.  None of the fluorescent features 
change location from frame to frame showing that, within our spatial resolution, they are not diffusing.  
Moreover, all the molecules, with the exception of the one in the center marked by an arrow, have 
distinct emission shapes that do not evolve with time.  This shows that their emission dipole orientation 
is not changing on this time scale.  The single molecule emission feature in the center of the frames, 
however, is clearly changing shape from frame to frame reflecting changes in its orientation on the time 
scale of the experiment.  The middle and bottom panels in Fig. 6.7 display the simulated emission 
pattern and schematic orientation, respectively, for the molecule in each frame.   
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Figure 6.7:  Top panel:  Timelapse images of a 5 μm x 6 μm region in a DPPC bilayer formed by 
vesicle fusion at 13% RH at 1s integration time, with the corresponding polar (Φ) and azimuthal (θ) 
angles extracted from the fluorophore in the center.  While the dye does not exhibit lateral movement 
through the capture, reorientation of the emission dipole is resolved and extracted.  The middle panel 
shows the simulated emission pattern used to determine the three-dimensional orientation in each 
capture.  A schematic illustration of the emission dipole orientation is displayed in the bottom panel. 
 
This shows that even at low membrane hydration levels, acyl chain fluidity is at least partially 
maintained and may be detected in real time using the single molecule orientation measurements.  As 
the RH is elevated further, the hydrodynamic radius of the headgroup becomes sufficient to overcome 
the activation barrier for diffusion and some lipids can laterally diffuse in the plane of the membrane.  
These results suggest that single molecule orientation measurements offer a minimally invasive view 
into membrane structure and dynamics that are complementary to other bulk measures of membrane 
properties.20, 30, 33  One can envision measurements such as these providing further insight into 
biologically important processes such as membrane fusion.  Membrane fusion is thought to proceed 
through localized dehydration events that may be reflected in changes in single molecule orientation 
and dynamics.78-85 
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6.4 Conclusions 
Single molecule fluorescence measurements of BODIPY-PC doped into membranes in trace 
amounts have been used to probe the structure and dynamics of DPPC bilayers as a function of RH.  
Bilayers formed from vesicle fusion and the LB/LS method are compared and found to follow similar 
trends when the LB/LS bilayers are transferred at a surface pressure of 23 mN/m.  This agrees with 
previous studies suggesting supported bilayers formed from vesicle fusion have an equivalent surface 
pressure of ∼23 mN/m.15  At all hydration levels studied, bimodal distributions of emission dipole 
orientations are observed which shifts as a function of RH.  As the RH increases, the population of 
molecules oriented normal to the membrane plane decreases while the population lying in the plane 
increases.   These shifts are consistent with an increase in the hydrated radius of the lipid headgroup as 
RH is elevated, increasing the area per lipid.   
At all RHs studied, a small population of the BODIPY-PC dye molecules laterally diffuse in the 
membrane plane.  The population of diffusing molecules increases exponentially with RH reaching a 
maximum of 6 % of the population at a RH of 95%.  Even at low RH levels where lateral diffusion is rare, 
orientation dynamics can still be observed through changes in the single molecule emission pattern.  
Single molecule orientation measurements, therefore, are shown to be a complementary new technique 
for probing changes in both membrane structure and dynamics.  Since only trace amounts of the 
fluorescent lipid probe are required, this approach introduces a minimal perturbation to the membranes 
under study.  Moreover, since these are single molecule measurements, the method does not suffer 
from loss of information due to ensemble averaging that may complicate bulk measures of membrane 
properties.  This seems especially useful for biological membranes that are characterized by their 
inherent heterogeneity. 
These studies have validated the single-molecule technique for measuring orientations and 
probing molecular level structure.  Now that the method is well-characterized, this approach can be 
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applied for determining antibody orientations as a function of immobilization protocol.  Future studies 
will be directed toward gaining a better understanding of how immobilization protocol affects antibody 
orientation and how these processes may be optimized to provide maximal binding kinetics in 
immunosensor assays. 
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Chapter 7:  Future Directions 
7.1 Introduction 
 Through the studies discussed in Chapters 5 and 6, a single-molecule fluorescence orientation 
method has been adapted to examine well-characterized model membrane systems.  These test 
systems assisted in further characterizing the technique while at the same providing insight into 
heterogeneous lipid film structure at the molecular level.  The next step for this work is to utilize the 
single-molecule approach to monitor the effect that different preparation chemistries have on the 
orientations of immobilized antibodies.  Understanding the effects of immobilization protocols on 
antibody orientation and capture efficiency is paramount for improving sensor performance.   
 Sensing performance may also be improved by using a shorter wavelength excitation in the 
WGM approach.  Evidence suggests that shorter wavelengths will reduce the mode volume of the 
confined field and subsequently increase sensitivity to analyte binding on the WGM resonator.  In 
addition, dye loading, functionalization chemistry, and substrate properties are all known to influence 
resonator Q-factors, and each property should be examined to improve sensor performance. 
7.2 Characterization of the Orientation and Function of Surface Immobilized Antibodies 
 Having tested and validated the single-molecule orientation approach, this approach can now be 
extended to measure the effect of immobilization protocol on antibody orientation.   
 7.2.1 Antibody Binding to Fluorophore Probe for Direct Orientation Measurement 
 Initial work to determine absolute antibody orientation has begun using the antibody 4-4-20 as 
the model system.  This antibody has a strong binding affinity towards flourescein and will therefore be 
useful for probing the bound complex by measuring single molecule orientations.2-7  An advantage to 
using this as the model system is that the 4-4-20 antibody is readily available for purchase and has been 
studied extensively.4, 5  Moreover, it belongs to the IgG class of antibodies, which are the most abundant 
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class in serum, making these measurements relevant to commonly employed immunoassays.  This 
makes the 4-4-20 system an excellent model system for exploring immobilization methods, which can 
then be applied to future WGMI preparation protocols.   
 Figure 7.1 displays the crystal structure of the fluorescein-Fab complex of 4-4-20 showing the 
fluorescein immobilized by surrounding protein interactions.4, 5  Having the crystal structure on hand will 
assist in interpreting the resulting data, as the exact orientation of the binding site is known.  One 
complication of this work is that the florescein is quenched ~95% when complexed with the antibody 
due to nearby aromatic residues.2, 3  This would make single-molecule measurements problematic given 
the reduced emission.  Fortunately, the 4-4-20 monoclonal antibody raised against flourescein is known 
to cross-react with dyes of similar structure, which have shown reduced quenching following binding.8  
One potential marker is Fluo-3, which exhibits <32% quenching while bound thus enabling single 
Figure 7.1:  Ribbon view of the fluorescein/4-4-20 Fab complex.  The heavy chain is 
highlighted blue and the light chain is colored yellow.4, 5 
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 This technique will be used to examine various immobilization strategies to determine their 
effect on antibody binding efficiency and orientation.  The advantage to this approach is that the 
reporter molecule used for antibody measurement is bound by the immunogen.  An absence of 
fluorescence after immobilization chemistry will therefore indicate antibody denaturation.  This 
advantage will allow us to not only determine the absolute orientation of bound antibodies as a function 
of immobilization protocol, but also distinguish between techniques that result in loss of biomolecule 
function due to denaturing conditions.  Using this information, we will employ the functionalization 
techniques found to be most efficient in our whispering gallery sensors to assist in maximizing sensor 
performance. 
7.3 Additional Experiments to Improve Sensor Performance 
 In addition to exploring optimal antibody immobilization protocols, sensing performance can be 
improved through modifications that alter the mode volume and increase Q.  This section discusses 
some of these strategies and how they may increase analytical performance of the WGMI approach. 
Figure 7.4:  Schematic representation of the 4-4-20/Fluo-3 complex in various orientations and 
the resulting single molecule fluorescence emission patterns.  The emission dipole of the 
reporter is indicated by the blue double arrow. 
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7.3.1 Mode Volume Reduction 
 One major difference between our WGM measurements and previous work in WGM detection 
revolves around the excitation wavelength employed.  The tunable laser used in this work is centered 
at 633 nm, however most studies in this field utilize longer wavelengths for WGM excitation, ranging 
from 980-1550 nm.9-14  Our approach leads to a significant reduction in the resonator mode volume 
which may be responsible for the enhanced sensitivity discussed in Chapter 2.  The mode volume (V) 
for a spherical resonator as estimated by Matsko and Ilchenko is:15 
= 3.4 ∗ ⁄ ∗ ⁄ √ − + 1   Eq. 7.1 
where  is the angular momentum number for a sphere,  is the refractive index,  is the mode 
number, and  is the wavelength confined within the resonator.  What is important to note in this 
equation is the cubed dependence of mode volume on the excitation wavelength.  As this wavelength 
decreases, therefore, a significant reduction in the mode volume is observed.  Armani et al. has 
reported that the resonant wavelength shift experienced by optical resonators has an inverse 
dependence on the mode volume.16  This suggests that small decreases in excitation wavelength, 
therefore, can have a significant effect on sensor response. 
 Future work will explore this effect using identical immunoassay procedures as performed in 
previous chapters while measuring resonant wavelength changes with spectrally separated excitation 
sources.  If the increase in sensor response is significant as expected, this provides a straightforward 
approach for substantially improving WGM sensitivity and detection limits. 
7.3.2 Dye Loading Effects on Q-Factor 
 An inherent issue that limits the resonator Q-factor in the WGMI design is that the microspheres 
are functionalized with a fluorescent dye.  Light stored within the resonator cavity experiences an 
additional loss due to absorption by the bound fluorophore.  In the case of labeled resonators the 
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dependence of Q-factor on material attenuation,  becomes more important.  The relationship is 
given by Eq. 7.2:17 =       Eq. 7.2 
where  is the refractive index of the resonator,  is the material attenuation, and  is the wavelength 
supported within the cavity.  Normally, this attenuation is only dependent on the resonator material, 
however the introduction of a fluorescent dye will increase these effects.  Since the current fluorescence 
signals obtained from the microsphere resonators are more than sufficient to characterize a resonance 
(S/N ranges from 5-50), a reduction in dye loading could assist in increasing the Q-factor and improving 
sensor performance.   
7.4 Summary 
 We have demonstrated in chapters 2 & 3 that the WGM technique can be utilized for refractive 
index measurements and biomarker measurement in both buffered systems and clinical human sera.  
With the current design, the WGMI technique has already exhibited detection limits in human serum 
that are improved over traditional ELISA methods (~2 U/mL CA-125 using WGMI versus ~5 U/mL using 
ELISA).  Using the studies performed on optimizing antibody orientations and combining these efforts 
with reduced mode volume and minimized dye loading to increase resonator performance, we hope to 
improve these detection limits even further for a highly sensitive, multiplexed assay for biomarker 
detection.   
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